Compounds > glutamine

glutamine and Benign Neoplasms, Brain

glutamine has been researched along with Benign Neoplasms, Brain in 81 studies

Research

Studies (81)

TimeframeStudies, this research(%)All Research%
pre-19907 (8.64)18.7374
1990's7 (8.64)18.2507
2000's18 (22.22)29.6817
2010's40 (49.38)24.3611
2020's9 (11.11)2.80

Authors

AuthorsStudies
Allen, JW; Ekici, S; Fleischer, CC; Neill, SG; Nye, JA; Shu, HK1
Jin, Y; Song, D; Xu, Z; Ye, L; Zhang, L1
Chinnaiyan, P; Cho, K; Dunphy, MP; Frankfater, C; Gass, H; Graham, MS; Grkovski, M; Ippolito, JE; Jones, JK; Krebs, S; Luo, J; Mauguen, A; Nunez, E; Patti, GJ; Rubin, JB; Schaefer, J; Spitz, DR; Sponagel, J; Tinkum, KL; Tung, O; Zhang, S1
Chen, H; Huang, Y; Li, C; Li, Z; Liang, Y; Liu, Y; Wu, Z; Zhang, L1
Karpel-Massler, G; Nguyen, TTT; Shang, E; Siegelin, MD1
Cai, F; Chen, F; DeBerardinis, RJ; Gao, X; Ge, WP; He, F; Lin, H; Liu, W; Luo, B; Sun, W; Vu, HS; Xing, C; Xiong, N; Xu, H; Yao, DX; Yuan, Y; Zacharias, LG; Zhang, FC; Zhao, H1
Aasen, T; Abdul Moin, NI; Abdul Wafi, S; Aboukameel, A; Abu-Bakar, N; Acharya, A; Ackermans, L; Adaramoye, O; Adarsh, KV; Adeosun, WA; Ahmad, NH; Ahmadi, F; Akanni, O; Akbar, M; Akbulak, RO; Akev, N; Akkaya, Ö; Al-Rashed, S; AlAbbad, S; Alabi, O; Alappat, BJ; Alcalá, S; Alcoutlabi, M; Aleppo, G; Alexander Ross, JB; Alexander, JH; Alexander, R; Alias, A; Alimba, C; Alken, FA; Allan, R; Alpers, M; Alsbou, EM; Amarasiri, SS; An, T; Anastasiadis, F; Anastassiadou, M; Anderson, KC; Andronikos, P; Anheyer, D; Annapurna, K; Anorlu, RI; Anten, MM; Anthopoulos, TD; Araujo-Castillo, RV; Aravamudhan, S; Arawwawala, LDAM; Arulsamy, N; Arunamata, A; Asghar, A; Asiri, AM; Aslanidou, T; Astrakhantseva, IV; Astutik, E; Attanayake, AP; Atwater, BD; Audureau, E; Augusto, S; Bakare, A; Banach, M; Bandelier, P; Banerjee, S; Barral, M; Bascuñán, J; Bates, FS; Bauer, NJC; Bayrak, BB; Beck, RW; Beckervordersantforth, J; Beeri, R; Begum, R; Beldi-Ferchiou, A; Bellingham, G; Ben-Tal, N; Bendib, I; Bergenstal, RM; Berger, MF; Bernasconi, G; Berry, S; Beuvon, F; Bi, WJ; Bi, Z; Bianconi, V; Bibi, I; Blank, BR; Bliemeister, E; Bobkowski, W; Bode, AM; Booth, CM; Bose, U; Boyd, K; Brancato, A; Brenmoehl, J; Brogi, E; Bronzo, P; Brooks, T; Brown, D; Brown, DN; Bruce, D; Buan, MEM; Bueno-Hernández, F; Bugielski, B; Bulavaitė, A; Buscagan, TM; Buxton, R; Caffaro, MM; Cai, Q; Cai, X; Cai, Y; Calhoun, P; Callander, N; Cambier, S; Camparo, P; Canales-Vargas, EJ; Canham, K; Cantu, J; Cao, J; Cao, JW; Cao, P; Cao, T; Cao, X; Caravella, BA; Carcadea, E; Carè, J; Carmichael, P; Carrasco Cabrera, L; Carteaux, G; Carvalho, PDS; Casarez, E; Cazorla, M; Celestrin, CP; Chakraborty, NK; Chan, B; Chandarlapaty, S; Chandgude, AL; Chang, CC; Chang, JH; Chang, X; Chang, Y; Chankhanittha, T; Chantanis, S; Chapovetsky, A; Chavan, S; Chen, B; Chen, D; Chen, F; Chen, G; Chen, H; Chen, J; Chen, K; Chen, KJ; Chen, KP; Chen, L; Chen, MA; Chen, Q; Chen, S; Chen, W; Chen, WF; Chen, X; Chen, Y; Cheng, D; Cheng, J; Cheng, Q; Cheon, GJ; Chiu, SC; Cho, CH; Cho, J; Choi, H; Choi, JS; Choi, YH; Christie, P; Chu, CH; Chu, Y; Chung, DH; Chung, F; Cline, JP; Cohen, A; Cohen, AD; Cohen, NJ; Comen, E; Compter, I; Cong, J; Cong, Z; Cooper, A; Cornud, F; Costa, C; Costa, S; Covey, A; Cowan, AM; Cramer, H; Cruz-Rivera, C; Cui, J; Cui, M; Cui, Y; Cui, YH; Culquichicón, C; Cushman, T; D'Auria, SJ; da Silva, J; Dalgediene, I; Danenberg, HD; Das, S; Dasgupta, K; Daubit, IM; de Oliveira, PD; de Prost, N; De Ruysscher, D; Dearman, K; Decato, D; Delfau-Larue, MH; Deng, L; Dhakate, SR; Dharuman, V; Di Costanzo, N; Dickler, MN; Dinehart, EE; Ding, D; Dinh, TK; Divya, KP; Djifack Tadongfack, T; Do, T; Domínguez-Roldan, R; Domínguez-Zambrano, E; Dömling, A; Donato, MD; Dong, JH; Dong, W; Dong, X; Dong, XR; Dong, Y; Dong, Z; Downs, M; Drutskaya, MS; Du, B; Du, F; Du, H; Du, L; Du, X; Duan, Z; Duangthip, D; Dunstand-Guzmán, E; Duong, F; Eckert, DJ; Edelhäuser, BAH; Eekers, DBP; Efendi, F; Efraimidis, P; Ehrenberg, H; Ehsanbakhsh, Z; Eickholt, C; Eksterowicz, J; El Mobadder, M; El-Araby, IE; El-Magd, MA; El-Tarabany, MS; Elgorban, AM; Engelmann, D; English, KL; Esfandiari, H; Eslami, B; Espinosa-Cuevas, A; Eswara, S; Faber, E; Fan, XH; Fan, Y; Fang, J; Fang, Z; Fantin, VR; Fei, P; Feng, G; Feng, H; Feng, J; Feng, X; Feng, XJ; Fennell, TR; Fernández-Moreira, V; Ferraz, ABF; Ferreras, KN; Flores, K; Flores-Pérez, I; Flox, C; Fluharty, FL; Fokouong Tchoffo, E; Folefack, GO; Foroutan, T; Fort, D; Fourati, S; Fousas, S; Frapard, T; Freguia, S; Friedman, DJ; Friedman, LS; Fu, D; Fu, Q; Fu, Y; Fujinami, S; Furihata, K; Gal, RL; Gan, H; Gao, C; Gao, F; Gao, R; Gao, SS; Gao, W; Gao, XC; Gao, Y; Gao, Z; Garozi, L; Ge, J; Georgiopoulos, A; Gerakiou, K; Ghazimirsaeed, SM; Ghazimirsaeed, ST; Gimeno, MC; Gjestad, R; Glurich, I; Goetchius, E; Goland, S; Goldstein, S; Gonçalves, CM; Gonçalves, H; Gong, Q; Gonzalez, D; Goplen, FK; Gorshkova, EN; Gotsman, I; Govindasamy, V; Granger, CB; Greco, L; Grigoriadou-Skouta, E; Grigoropoulos, P; Grivicich, I; Gromov, NV; Gruber, S; Grytczuk, M; Grzech-Leśniak, K; Gu, L; Gu, S; Gu, Z; Guadagnini, D; Guan, H; Guilliams, M; Guo, J; Guo, L; Gupta, A; Gupta, SK; Gurzu, S; Gutleb, AC; Haban, A; Hablitz, JJ; Hadisuyatmana, S; Hahn, S; Haiges, R; Hallal-Calleros, C; Hamed, M; Hammad, N; Hammer, N; Han, C; Hao, Y; Harnett, J; Has, EMM; Hassanpour, K; Hatzopoulos, D; Hawaldar, R; He, X; He, Y; He, YY; He, Z; Heberman, D; Heckl, D; Hegde, H; Henson, MA; Hernández-Velázquez, VM; Herrera, E; Hijazi, Z; Hirayama, K; Hirth, JM; Hoeben, A; Hohnloser, SH; Hong, M; Hood, K; Hoplock, LB; Hopman, WM; Horlbogen, LM; Hossein Rashidi, B; Hou, G; Hou, H; Hou, J; Hou, Y; Hu, J; Hu, W; Hu, X; Hua, W; Huang, G; Huang, H; Huang, J; Huang, T; Huang, W; Huang, Y; Huang, YD; Huang, Z; Hudis, CA; Hue, S; Huo, J; Hussain, M; Hvas, AM; Ichii, T; Ide Zeuna, J; Ilyas, S; Inoue, T; Iranzo, A; Irfan, M; Iwasa, Y; Iwashita, Y; Izgorodina, EI; J R, A; Jaber, WA; Jaborek, JR; Jacobus, SJ; Jadeja, SD; Jafarabadi, M; Jalan, D; Jamil, MI; Jarrah, S; Jarvis, D; Jayatilaka, KAPW; Jemal-Turki, A; Jeon, YK; Jeong, N; Jeong, SH; Jeong, SY; Jermy, M; Jhaveri, K; Ji, H; Ji, K; Ji, RY; Jiang, F; Jiang, J; Jiang, X; Jiang, Y; Jiao, Q; Jilani, K; Jiménez-Guerrero, P; Jin, L; Jo, YH; Johnson, JG; Johnson, ML; Jones, WS; Jose, S; Jularic, M; Jung, I; Jung, YJ; Jungen, C; Junttila, MR; Kache, S; Kahanovitch, U; Kalantzi, KI; Kallio, T; Kamnoedboon, P; Kang, CH; Kang, H; Kang, J; Kang, KW; Kapoor, P; Karmakar, D; Kartalis, A; Kauranen, P; Kazocina, A; Keikha, F; Keltai, M; Kershaw, SV; Kettani, M; Khalvati, S; Khandhar, S; Khosla, N; Kiely, CJ; Kim, CC; Kim, H; Kim, MJ; Kim, Y; Kim, YH; Kim, YT; Kimoto, E; Kiyu, A; Klatt, N; Kobayashi, M; Koh, J; Köhler, R; Kondadasula, SV; Kong, H; Kong, W; Kong, X; Kotidis, A; Kotwal, A; Kouvari, M; Kozhinov, AN; Kruger, D; Kuang, S; Kuang, Y; Kubota, M; Kuklik, P; Kumar, P; Kumar, SK; Kuo, YF; Kurup, SP; Kusuhara, H; Kuswanto, H; Lacouture, ME; Lambin, P; Lang, CC; Langroudi, FH; Lanman, RB; Larsen, OH; Laskin, J; Le, VH; Leach, M; Lee, BG; Lee, DF; Lee, DS; Lee, HJ; Lee, SB; Lee, YA; Lei, Y; Lekashvili, O; Lelj, F; Lemin, AS; Lemoine, J; Leuschner, R; Li, B; Li, BT; Li, C; Li, D; Li, F; Li, G; Li, H; Li, HW; Li, J; Li, M; Li, P; Li, Q; Li, S; Li, W; Li, X; Li, XY; Li, Y; Li, Z; Lian, Y; Liang, C; Liao, J; Liao, W; Liao, Y; Lin, D; Lin, W; Lin, YL; Lindbäck, J; Lindsay, AP; Ling, J; Linser, PJ; Liu, C; Liu, H; Liu, JJ; Liu, L; Liu, Q; Liu, SF; Liu, X; Liu, Y; Liu, Z; Liu, ZM; Lo Sterzo, C; Lo, ECM; Lobchuk, MM; Lodge, TP; Logotheti, S; Lonial, S; Lopes, G; Lopes, RD; Lopez, J; Lopez, SA; López-Santos, AL; López-Sendón, JL; Loring, Z; Louis, C; Lovita, AND; Lu, DZ; Lu, H; Lu, J; Lu, K; Lu, TT; Lu, Y; Luengo, A; Lum, LG; Luna, JM; Luo, L; Luo, R; Luo, T; Luo, X; Luo, Z; Lv, B; Lymperopoulos, N; Lyras, A; Lyu, Y; M Kannan, A; Ma, H; Ma, M; Ma, Q; Ma, S; Ma, WY; Ma, Y; Maalouf, E; Machado, FA; Maeda, K; Magrans, JO; Maharani, A; Maia, G; Mainwaring, RD; Maji, TK; Majumdar, K; Mannarino, MR; Mansuri, MS; Marinescu, SC; Markatos, G; Marquardt, S; Marraiki, N; Martens, C; Martínez, TJ; Marumo, K; Maruyama, H; Marwani, HM; Marzo, I; Masrati, G; Matamba, P; Mathialagan, S; Matys, J; Mayatra, JM; Mboua, PC; McArthur, T; McCrimmon, RJ; McIntosh, S; McSpadden, S; Medina-Campos, ON; Medvedovsky, AT; Mei, Z; Mekontso-Dessap, A; Menezes, AMB; Meng, J; Meng, P; Meng, Y; Menter, A; Mets, MB; Mets-Halgrimson, R; Metzger, T; Metzler-Nolte, N; Meyer, C; Mi, Y; Michailoviene, V; Mikrogeorgiou, A; Militz, H; Miller Iii, TF; Minarowska, A; Mir, S; Miron, I; Miyake, T; Moayer, F; Modi, S; Moeller, SJ; Mohamad, MN; Mohammed, EHM; Mokhonov, VV; Mondal, A; Moore, J; Moravcova, M; Mordi, IR; Mordi, NA; Mortensen, NP; Moscariello, C; Moser, J; Moynahan, ME; Mu, J; Mu, W; Mudduwa, LKB; Mukherjee, S; Mukhtar, A; Mulkey, DK; Murr, N; Mushtaq, Z; Muthuswamy, N; Mutlu, O; Muto, C; Myroforou, I; Na, KJ; Nabi, M; Nagornov, KO; Nagy, RJ; Naik, A; Nakajima, K; Nam, KT; Nam, YW; Namburath, M; Nammour, S; Namour, A; Namour, M; Nanan, S; Natsume, H; Nave, S; Naveed, A; Nazir, H; Ndubaku, C; Nedospasov, SA; Neradilek, MB; Newcomb, C; Nguépy Keubo, FR; Nguyen, M; Ning, J; Ning, Q; Noguchi, S; Nordahl, SHG; Nordfalk, KF; Norton, L; Noupoue, EM; Nouri, SS; Nowak, JK; Núñez, K; Oakes, K; Odegaard, JI; Ogorodnikova, OL; Ogunsuyi, O; Oh, HK; Oh, HR; Oh, KH; Ohgi, K; Okunade, KS; Oliveira, AG; Olorunfemi, G; Olsen, ML; Olson, BA; Omari, KW; Ondruschka, B; Orfali, R; Orkopoulos, A; Orlowski, RZ; Oser, SM; Oser, TK; Özcan, M; Padilla, V; Paeng, JC; Pajuelo-Lozano, N; Pal, SK; Palmieri, S; Palomeque, E; Pan, W; Panagiotakos, DB; Pandey, M; Pang, D; Pang, Q; Pangarah, CA; Panny, A; Paparella, A; Papirio, S; Papouskova, K; Parang, K; Park, HJ; Park, IK; Park, S; Parker, TL; Parkhomenko, A; Parmon, VN; Parsons, B; Parsons, J; Patel, PR; Patil, S; Patsourakos, NG; Patterson, KC; Pavlidis, P; Pedernera, M; Pedersen, R; Pedraza-Chaverri, J; Pellegrini, M; Peña-Chora, G; Pereira, EDM; Pereira, MADS; Peretz, A; Perez-Padilla, R; Perlman, GY; Perona, R; Petras, C; Phuntsho, S; Picada, JN; Pinder, TA; Piper, LFJ; Pirozzi, F; Pirro, M; Pleckaityte, M; Ploutz-Snyder, LL; Ploutz-Snyder, R; Pogorzelski, A; Poles, L; Postma, AA; Prager, A; Prakash, J; Punn, R; Pützer, BM; Qi, J; Qi, MC; Qi, Y; Qian, J; Qian, Y; Qiang, L; Qiu, J; Qu, Y; Rabiu, KA; Rahighi, S; Rahman, MM; Rahmani, B; Rajkumar, SV; Ramanathan, R; Raras, TYM; Rashi, Y; Rasool, G; Rathore, MG; Ratnawati, R; Ratola, N; Raucci, U; Ray, SK; Razavi, P; Razazi, K; Razek, S; Razi, SS; Reback, M; Reddy, K; Rees, DC; Reginatto, FH; Reich, H; Reis-Filho, JS; Ren, X; Ren, Y; Renner, G; Rey, G; Reymen, B; Riaz, M; Ricci, A; Richardson, PG; Richter, C; Riga, M; Ritchie, C; Rivoal, S; Roberts, W; Robson, ME; Rocha, GZ; Rodrigues, AD; Rogach, AL; Rojas, A; Rosenberg, A; Rosenberg, E; Rosenheck, RA; Roslan, K; Rothenberger, C; Rouschop, KMA; Rubagumya, F; Ryan, CM; Ryder, JW; Saad, MJA; Sacan, O; Sacchi, A; Sahebkar, A; Saini, A; Sainz, B; Sajo, EA; Sakizadeh, J; Saleh, AA; Salgado Júnior, IB; Salvi, R; Samoylova, YV; Samuni, A; Sanchez, DM; Sanchez-Perez, I; Santos, M; Sarapulova, A; Sardot, T; Saud, N; Sauerbier, P; Scaltriti, M; Schaeffer, B; Schalk, DL; Scherschel, K; Schijven, MP; Schreuder, HWR; Schuhmacher, M; Schultz-Lebahn, A; Schwarzl, J; Scott, JM; Sebayang, SK; Seeger, ZL; Segabinazi Peserico, C; Selenica, P; Serio, A; Seruga, B; Shah, A; Shah, C; Shah, PD; Shahrokh Tehraninezhad, E; Shan, A; Shao, Z; Sharma, AMR; Sharma, RK; Shen, J; Shen, R; Shi, X; Shi, Y; Shi, ZE; Shih, YC; Shimohata, H; Shimpi, N; Shin, SH; Shon, HK; Shuvy, M; Siddique, AB; Siegbahn, A; Sikandar, M; Silvani, Y; Singh, A; Singh, AK; Singh, D; Singh, JS; Singh, KP; Singh, M; Situ, B; Skipper, MT; Skouloudi, M; Sloane, BF; Smyrnioudis, N; Snyder, MA; Söhnchen, C; Solis Condor, R; Solit, DB; Someya, S; Song, H; Song, J; Song, W; Song, Y; Sorokina, KN; Soshi, S; Soyer, P; Spitschak, A; Sreekrishnan, TR; Srinivasan, M; Staruschenko, A; Steel, A; Stefan-van Staden, RI; Stein, AM; Strayer, H; Struthers, AD; Su, H; Su, Q; Su, X; Sudore, RL; Sugimura, H; Sugiyama, Y; Sujuti, H; Sumner, SJ; Sun, B; Sun, D; Sun, H; Sun, J; Sun, JY; Sun, X; Sun, Y; Sun, Z; Sung, YC; Surenaud, M; Sutimantanapi, D; Suwandaratne, NS; Swaroop, S; Sychrova, H; Syed, A; Szczepanik, M; Szederjesi, J; Szodorai, R; Tacy, TA; Tadelle, RM; Takayasu, M; Tammeveski, K; Tan, H; Tan, M; Tang, HX; Tang, S; Tang, X; Tanokura, M; Tao, F; Tao, H; Tarafdari, A; Tarín-Carrasco, P; Tasson Tatang, C; Teixeira, JP; Thakur, A; Theobald, A; Thevenot, P; Thomaidis, K; Tian, J; Tillib, SV; Toma, C; Tomita, M; Tonchev, I; Tong, F; Toy, W; Trypuć, M; Tselepis, AD; Tsetseris, L; Tsikouri, GE; Tsikouris, EI; Tsoplifack, CB; Tsoumani, ME; Tsujimoto, R; Tsybin, YO; Tu, J; Tu, TM; Turco, M; Turkyilmaz, IB; Uddin, MJ; Ung, J; Unsihuay, D; Utsunomiya, T; Vagenende, B; Vaishnav, J; Valdes, C; Validad, MH; Valle, J; van Ginkel, MPH; van Grevenstein, WMU; Vanderpuye, V; Vasan, N; Vasilenko, EA; Vasques, GJ; Vavoulis, P; Verani, A; Veziroglu, E; Viegas, A; Vitali, MG; Vitsas, G; Voccio, JP; Vogiatzidis, C; Volow, A; Volpin, F; Vourvahis, M; Wagner, LI; Walkowiak, J; Wallace, R; Wallentin, L; Wan, D; Wan, L; Wan, T; Wang, C; Wang, F; Wang, FN; Wang, H; Wang, J; Wang, L; Wang, Q; Wang, S; Wang, T; Wang, W; Wang, X; Wang, XW; Wang, Y; Wang, YS; Wang, Z; Ward, J; Ward, L; Waseem, R; Watson, DF; Weber, P; Wehrmeister, FC; Wei, CH; Wei, H; Wei, L; Wei, Q; Wei, Y; Weinstock, RS; Weiss, M; Welborn, M; Wen, L; Wen, LM; Wen, Q; Wen, Z; Wesseling, P; Westerbergh, J; White, K; Wick, MP; Willems, S; Wiyasa, IWA; Wójciak, R; Wolkenhauer, O; Won, HH; Wong, J; Woo, YC; Wood, LS; Wu, CT; Wu, CY; Wu, D; Wu, G; Wu, J; Wu, K; Wu, M; Wu, Q; Wu, T; Wu, W; Wu, X; Wu, XT; Wu, Y; Xi, D; Xi, J; Xiang, W; Xiang, Y; Xiao, M; Xiao, Z; Xie, H; Xie, Q; Xie, S; Xie, X; Xing, M; Xing, YL; Xu, C; Xu, X; Xu, Y; Xu, Z; Xue, F; Xue, XD; Yaglioglu, HG; Yamada, H; Yamashita, M; Yan, W; Yan, Z; Yanardag, R; Yang, D; Yang, H; Yang, K; Yang, QQ; Yang, R; Yang, S; Yang, T; Yang, X; Yang, Y; Yao, H; Yao, Y; Yari, D; Yassin, MT; Ye, C; Ye, J; Ye, Q; Yildiz, EA; Ying, S; Yoon, H; Yu, D; Yu, K; Yu, N; Yu, PL; Yuan, C; Yuan, D; Yuan, LJ; Yuan, Z; Yuen, N; Zagatto, AM; Zakaria, Y; Zalewski, AM; Zamora, S; Zavorotinskaya, T; Zeid, JL; Zeinoun, T; Zeng, C; Zerby, HN; Zhan, X; Zhang, A; Zhang, D; Zhang, E; Zhang, F; Zhang, H; Zhang, J; Zhang, L; Zhang, M; Zhang, P; Zhang, Q; Zhang, QY; Zhang, RG; Zhang, S; Zhang, T; Zhang, X; Zhang, Y; Zhang, YY; Zhao, CK; Zhao, H; Zhao, J; Zhao, K; Zhao, Q; Zhao, S; Zhao, T; Zhao, XQ; Zhao, Y; Zhao, Z; Zheng, J; Zheng, L; Zheng, Y; Zhou, B; Zhou, G; Zhou, L; Zhou, T; Zhou, X; Zhu, C; Zhu, J; Zhu, Y; Zhu, ZQ; Zhuang, T; Zimmermannova, O; Zin, NNINM; Zisimos, K; Zoghebi, KA; Zonder, JA; Zou, C; Zwirner, J1
Ekici, S; Fleischer, CC; Neill, SG; Risk, BB; Shu, HK1
Bamba, T; Fujita, Y; Hashiguchi, M; Hosoda, K; Irino, Y; Izumi, Y; Kitta, A; Kohmura, E; Kohta, M; Kyotani, K; Nagashima, H; Nakai, T; Sasayama, T; Satoh, N; Shinohara, M; Takahashi, M; Tanaka, K; Uno, T; Uozumi, Y1
Barbosa, M; Cardoso, AM; Jurado, AS; Morais, CM; Pedroso de Lima, MC; Rebelo, O; Sousa, M; Tão, H1
Albuquerque, CP; Bi, J; Braas, D; Christofk, HR; Cloughesy, TF; Gahman, TC; Gini, B; Gu, Y; Guan, KL; Ikegami, S; Masui, K; Mischel, PS; Shiau, AK; Villa, GR; Yang, H; Zhang, W; Zhou, H1
Alves-Guerra, MC; Chauvin, C; Compan, V; Gautier, F; Geraldo, F; Gratas, C; Jarry, U; Loussouarn, D; Martinou, JC; Oizel, K; Oliver, L; Pecqueur, C; Rabe, M; Scotet, E; Teusan, R; Vallette, FM1
Bachoo, RM; Baskin, DS; Ijare, OB; Maher, EA; Malloy, CR; Marin-Valencia, I; Mashimo, T; Mickey, BE; Pichumani, K; Vemireddy, V1
Kung, HF; Li, N; Liu, F; Xu, X; Yang, J; Yang, Z; Zhang, L; Zhang, Y; Zhu, H; Zhu, L1
Arismendi-Morillo, G; Elsakka, A; Kalamian, M; Maroon, J; Mukherjee, P; Seyfried, TN; Shelton, L1
Arismendi-Morillo, G; Augur, ZM; Bronson, RT; Chinopoulos, C; Domin, MA; Greenwood, B; Hill, C; Kiebish, MA; Kondakci, G; Li, M; Mukherjee, P; Narain, NR; Seyfried, TN1
Batsios, G; Gillespie, AM; Molloy, AR; Najac, C; Pieper, RO; Ronen, SM; Santos, RD; Subramani, E; Viswanath, P1
Bakalara, N; de Weille, J; Fabre, C; Gaven, C1
Bachoo, R; Choi, C; Deberardinis, R; Dimitrov, I; Ganji, S; Hulsey, K; Kovacs, Z; Madan, A; Maher, E; Malloy, C; Mendelsohn, D; Mickey, B; Pichumani, K; Zhang, S1
Cloughesy, TF; Kornblum, HI; Laks, DR; Lasky, JL; Lee, WN; Lin, HJ; Moore, TB; Pak, Y; Panosyan, EH; Wang, Y; Xia, P1
Ito, M; Kato, K; Kato, Y; Motomura, A; Motomura, K; Natsume, A; Ohka, F; Ranjit, M; Saito, K; Senga, T; Soga, T; Wakabayashi, T1
Bjerkvig, R; Leenders, WP; Molenaar, R; Navis, AC; Niclou, SP; Tops, B; van Lith, SA; van Noorden, CJ; Verrijp, K; Wesseling, P1
D'Agostino, DP; Flores, R; Mukherjee, P; Poff, AM; Seyfried, TN1
Bähr, O; Bjerkvig, R; Espedal, H; Fack, F; Golebiewska, A; Gottlieb, E; Harter, PN; Keunen, O; Lund-Johansen, M; Miletic, H; Mittelbronn, M; Niclou, SP; Obad, N; Rygh, CB; Sakariassen, PØ; Stieber, D; Stuhr, L; Weyerbrock, A; Zheng, L1
Bachoo, RM; Banerjee, A; Choi, C; Hulsey, KM; Maher, EA; Mashimo, T; Soesbe, TC; Spence, JS; Vemireddy, V1
Babic, I; Chao, Y; Cho, YJ; Crawford, JR; Fogal, V; Jiang, P; Kesari, S; Mukthavaram, R; Pastorino, S; Piccioni, DE; Pingle, SC1
Brennan, CW; Campos, C; Carlin, SD; Cross, JR; Dunphy, MP; Holland, EC; Kung, HF; La Rocca, G; Lewis, JS; Lyashchenko, S; Mellinghoff, IK; Omuro, AM; Pitter, KL; Ploessl, K; Rohle, D; Thompson, CB; Venneti, S; Weber, WA; Zanzonico, P; Zhang, H1
Ejima, Y; Gini, B; Hosoda, K; Imahori, T; Irino, Y; Kohmura, E; Kyotani, K; Masui, K; Mischel, PS; Mizowaki, T; Nagashima, H; Sasaki, R; Sasayama, T; Satoh, N; Takata, K; Tanaka, K; Yang, H1
Burzynski, GS; Burzynski, SR; Janicki, TJ; Marszalek, A1
Ahmed, SU; Barnett, SC; Bjerkvig, R; Chalmers, AJ; Fack, F; Gottlieb, E; Hock, AK; Keunen, O; Lindsay, SL; Lund-Johansen, M; Miletic, H; Mørkve, SH; Niclou, SP; Oudin, A; Ruppin, E; Sakariassen, PØ; Tardito, S; Wagner, A; Weinstock, A; Zheng, L1
Christofk, HR; Krall, AS1
Heath, JR; Johnson, D; Su, Y; Wei, W; Xue, M1
Beckmann, K; Carrera, I; Dennler, M; Kircher, PR; Meier, D; Richter, H1
Aoun, RJ; Bendok, BR; Panchanathan, RS; Pines, AR; Sittur, MG; Swanson, KR1
Gottschalk, M; Grand, S; Lamalle, L; Le Bas, JF; Segebarth, C; Troprès, I1
D'Orazio, F; Di Cesare, E; Patriarca, L; Splendiani, A1
Carro, MS; Heiland, DH; Lange, T; Mader, I; Pfeifer, D; Schlosser, P; Schwarzwald, R; Urbach, H; Vasilikos, I; Weyerbrock, A1
Adams, R; Alt, J; Elgogary, A; Englert, J; Ferraris, D; Jančařík, A; Le, A; Majer, P; Monincová, L; Nedelcovych, M; Pate, K; Powell, J; Rais, R; Rojas, C; Slusher, BS; Tan, J; Tenora, L1
Albrecht, J; Szeliga, M1
Chen, L; Fan, J; Li, Y; Liu, Z; Wang, J; Xu, R1
Cai, Q; Hawke, D; Jiang, BH; Jiang, T; Jiang, Y; Lee, JH; Li, X; Liu, DX; Lu, Z; Qian, X; Wang, Y; Xia, Y; Yu, Q; Zhang, C; Zheng, Y1
Alonso, FJ; Campos-Sandoval, JA; Márquez, J; Martín-Rufián, M; Matés, JM; Segura, JA1
Aguilera, C; Alonso, J; Arús, C; Castañer, S; Julià-Sapé, M; León, A; Majós, C; Rovira, A; Samitier, A; Sánchez, JJ1
Hou, BL; Hu, J1
Bock, HC; Buhk, JH; Dechent, P; Frahm, J; Giese, A; Helms, G; Jung, K; Kallenberg, K; Knauth, M; Strik, H; Wrede, A1
Huysentruyt, LC; Seyfried, TN; Shelton, LM1
Eloqayli, H; Haukvik, A; Melø, TM; Sonnewald, U1
Marie, SK; Shinjo, SM1
Acosta Escribano, J; Conejero García-Quijada, R; Herrero Meseguer, I1
Galeffi, F; Turner, DA1
Bachoo, RM; Baek, H; Cai, L; Cho, S; Deberardinis, RJ; Good, L; Hatanpaa, KJ; Maddie, M; Maher, EA; Malloy, CR; Marin-Valencia, I; Mashimo, T; Matés, JM; Mickey, BE; Pascual, JM; Rajagopalan, KN; Tu, BP; Vemireddy, V; Yang, C; Yang, XL; Zhao, Z1
Hubenia, OV; Kharkova, AP; Minchenko, DO; Minchenko, OH1
Acebes, JJ; Aguilera, C; Alonso, J; Arús, C; Gili, J; Majós, C; Serrallonga, M1
Bernsen, H; Boerman, R; Heerschap, A; Rijpkema, M; Schuuring, J; van der Graaf, M; van der Kogel, A; van der Meulen, Y1
Dezortová, M; Hájek, M; Liscák, R; Vladyka, V; Vymazal, J1
Hammer, MR; Jonas, WB1
McKnight, TR1
Bestak, M; Burzynski, SR; Janicki, TJ; Jurida, GF; Khan, MI; Lewy, RI; Szymkowski, BG; Weaver, RA1
Imbesi, SG; Niku, S; Panchal, NJ1
Burzynski, SR; Dolgopolov, V; Janicki, T; Jurida, G; Khan, M; Szymkowski, B; Weaver, RA1
Grand, S; Hoffmann, D; Le Bas, JF; Tropres, I; Ziegler, A1
Haacke, EM; Hu, J; Jiang, Q; Xuan, Y; Yang, S; Yang, Y1
Daikhin, E; DeBerardinis, RJ; Mancuso, A; Nissim, I; Thompson, CB; Wehrli, S; Yudkoff, M1
Colica, C; Costa, N; Mollace, V; Muscoli, C; Palma, E; Rotiroti, D; Sacco, I; Sculco, F; Visalli, V1
Hu, J; Kou, Z; Yang, S; Yang, Y1
Krivopusk, ME1
Hara, H; Hirohata, M; Maruiwa, H; Shigemori, M; Sugita, Y; Tsuda, H1
Burlina, AP; Hagberg, G; Mader, I; Radue, EW; Roser, W; Seelig, J1
Cooper, MR; Figg, WD; Headlee, DJ; McCall, NA; Samid, D; Sartor, AO; Thibault, A; Tompkins, AC; Venzon, DJ; Weinberger, MS1
Canioni, P; Martin, M; Merle, M; Portais, JC1
Ames, MM; Buckner, JC; Cascino, TL; Figg, WD; Lim, S; Malkin, MG; Reed, E; Reid, JM; Tong, WP1
Bouzier, AK; Canioni, P; Merle, M; Quesson, B; Valeins, H1
Décorps, M; Rémy, C; von Kienlin , M; Ziegler, A1
Bouzier-Sore, AK; Canioni, P; Merle, M1
Smigel, K1
Bruhn, H; Frahm, J; Gyngell, ML; Hamburger, C; Hänicke, W; Merboldt, KD; Sauter, R1
Bartel, R; Bigner, DD; Campbell, GL; Freidman, HS1
Bateman, DE; Edwardson, JA; Hardy, JA; McDermott, JR; Parker, DS1
Al-Mefty, O; el-Yazigi, A1
Greger, J; Hankowitz, M; Hemke, G; Kluge, H; Wieczorek, V1
Andreeva, TV; Promyslov, MSh1

Reviews

9 review(s) available for glutamine and Benign Neoplasms, Brain

ArticleYear
Glutamine Imaging: A New Avenue for Glioma Management.
    AJNR. American journal of neuroradiology, 2022, Volume: 43, Issue:1

    Topics: Brain Neoplasms; Glioma; Glutamine; Humans

2022
Psychological distress among health care professionals of the three COVID-19 most affected Regions in Cameroon: Prevalence and associated factors.
    Annales medico-psychologiques, 2021, Volume: 179, Issue:2

    Topics: 3' Untranslated Regions; 5'-Nucleotidase; A549 Cells; Accidental Falls; Acetylcholinesterase; Acrylic Resins; Actinobacillus; Acute Disease; Acute Kidney Injury; Adaptor Proteins, Signal Transducing; Adenosine; Adenosine Triphosphate; Administration, Inhalation; Administration, Oral; Adolescent; Adult; Advance Care Planning; Africa, Northern; Age Factors; Aged; Aged, 80 and over; Air Pollutants; Air Pollution; Air Pollution, Indoor; Albendazole; Aluminum Oxide; Anastomosis, Surgical; Ancylostoma; Ancylostomiasis; Androstadienes; Angiogenesis Inhibitors; Angiotensin II; Animals; Anti-Bacterial Agents; Anti-Infective Agents; Antibodies, Bispecific; Antibodies, Viral; Anticoagulants; Antihypertensive Agents; Antinematodal Agents; Antineoplastic Agents; Antineoplastic Agents, Immunological; Antineoplastic Combined Chemotherapy Protocols; Antioxidants; Antiporters; Antiviral Agents; Apoptosis; Aptamers, Nucleotide; Aromatase Inhibitors; Asian People; Astrocytes; Atrial Fibrillation; Auditory Threshold; Aurora Kinase B; Australia; Autophagy; Autophagy-Related Protein 5; Autotrophic Processes; Bacillus cereus; Bacillus thuringiensis; Bacterial Proteins; Beclin-1; Belgium; Benzene; Benzene Derivatives; Benzhydryl Compounds; beta Catenin; beta-Arrestin 2; Biliary Tract Diseases; Biofilms; Biofuels; Biomarkers; Biomarkers, Tumor; Biomass; Biomechanical Phenomena; Bioreactors; Biosensing Techniques; Biosynthetic Pathways; Bismuth; Blood Platelets; Bone and Bones; Bone Regeneration; Bortezomib; Botulinum Toxins, Type A; Brain; Brain Injuries; Brain Ischemia; Brain Neoplasms; Breast Neoplasms; Breath Tests; Bronchodilator Agents; Calcium Phosphates; Cannabis; Carbon Dioxide; Carbon Isotopes; Carcinogenesis; Carcinoma, Hepatocellular; Carcinoma, Non-Small-Cell Lung; Carcinoma, Squamous Cell; Cardiac Resynchronization Therapy; Cardiac Resynchronization Therapy Devices; Cardiomyopathies; Cardiovascular Diseases; Cariostatic Agents; Case Managers; Case-Control Studies; Catalysis; Cation Transport Proteins; CD8-Positive T-Lymphocytes; Cecropia Plant; Cell Adhesion; Cell Count; Cell Differentiation; Cell Division; Cell Line; Cell Line, Tumor; Cell Membrane; Cell Movement; Cell Proliferation; Cell Self Renewal; Cell Survival; Cells, Cultured; Cellular Reprogramming; Cellulose; Charcoal; Chemical and Drug Induced Liver Injury; Chemical Phenomena; Chemokines; Chemoradiotherapy; Chemoreceptor Cells; Child; Child Abuse; Child, Preschool; China; Chlorogenic Acid; Chloroquine; Chromatography, Gas; Chronic Disease; Clinical Competence; Coated Materials, Biocompatible; Cochlea; Cohort Studies; Color; Comorbidity; Computer Simulation; Computer-Aided Design; Contraception; Contraceptive Agents, Female; Contrast Media; COP-Coated Vesicles; Coronavirus Infections; Cost of Illness; Coturnix; COVID-19; Creatinine; Cross-Over Studies; Cross-Sectional Studies; Culex; Curriculum; Cyclic N-Oxides; Cytokines; Cytoplasm; Cytotoxicity, Immunologic; Cytotoxins; Databases, Factual; Deep Learning; Delivery, Obstetric; Denitrification; Dental Caries; Denture, Complete; Dexamethasone; Diabetes Complications; Diabetes Mellitus; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 2; Dielectric Spectroscopy; Diet, High-Fat; Dietary Fiber; Disease Models, Animal; Disease Progression; DNA; DNA Copy Number Variations; DNA, Mitochondrial; Dog Diseases; Dogs; Dopaminergic Neurons; Double-Blind Method; Down-Regulation; Doxorubicin; Drug Carriers; Drug Design; Drug Interactions; Drug Resistance, Bacterial; Drug Resistance, Neoplasm; Drug-Related Side Effects and Adverse Reactions; Drugs, Chinese Herbal; Dry Powder Inhalers; Dust; E2F1 Transcription Factor; Ecosystem; Education, Nursing; Education, Nursing, Baccalaureate; Electric Impedance; Electricity; Electrocardiography; Electrochemical Techniques; Electrochemistry; Electrodes; Electrophoresis, Polyacrylamide Gel; Endoplasmic Reticulum; Endothelial Cells; Environmental Monitoring; Enzyme Inhibitors; Epithelial Cells; Epithelial-Mesenchymal Transition; Esophageal Neoplasms; Esophageal Squamous Cell Carcinoma; Estrogen Receptor Modulators; Europe; Evoked Potentials, Auditory, Brain Stem; Exosomes; Feasibility Studies; Female; Ferricyanides; Ferrocyanides; Fibrinogen; Finite Element Analysis; Fistula; Fluorescent Dyes; Fluorides, Topical; Fluorodeoxyglucose F18; Fluticasone; Follow-Up Studies; Food Contamination; Food Microbiology; Foods, Specialized; Forensic Medicine; Frail Elderly; France; Free Radicals; Fresh Water; Fungi; Fungicides, Industrial; Galactosamine; Gastrointestinal Neoplasms; Gene Expression Profiling; Gene Expression Regulation, Neoplastic; Gene Frequency; Genetic Predisposition to Disease; Genotype; Gingival Hemorrhage; Glioblastoma; Glioma; Glomerular Filtration Rate; Glomerulosclerosis, Focal Segmental; Glucose; Glucose Transport Proteins, Facilitative; Glucosides; Glutamine; Glycolysis; Gold; GPI-Linked Proteins; Gram-Negative Bacteria; Gram-Positive Bacteria; Graphite; Haplotypes; HCT116 Cells; Healthy Volunteers; Hearing Loss; Heart Failure; Hedgehog Proteins; HEK293 Cells; HeLa Cells; Hemodynamics; Hemorrhage; Hepatocytes; Hippo Signaling Pathway; Histone Deacetylases; Homeostasis; Hospital Mortality; Hospitalization; Humans; Hydantoins; Hydrazines; Hydrogen Peroxide; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Hydroxylamines; Hypoglycemic Agents; Immunity, Innate; Immunoglobulin G; Immunohistochemistry; Immunologic Factors; Immunomodulation; Immunophenotyping; Immunotherapy; Incidence; Indazoles; Indonesia; Infant; Infant, Newborn; Infarction, Middle Cerebral Artery; Inflammation; Injections, Intramuscular; Insecticides; Insulin-Like Growth Factor I; Insurance, Health; Intention to Treat Analysis; Interleukin-1 Receptor-Associated Kinases; Interleukin-6; Intrauterine Devices; Intrauterine Devices, Copper; Iron; Ischemia; Jordan; Keratinocytes; Kidney; Kidney Diseases; Kir5.1 Channel; Klebsiella Infections; Klebsiella pneumoniae; Lab-On-A-Chip Devices; Laparoscopy; Lasers; Lasers, Semiconductor; Lenalidomide; Leptin; Lethal Dose 50; Levonorgestrel; Limit of Detection; Lipid Metabolism; Lipid Metabolism Disorders; Lipogenesis; Lipopolysaccharides; Liquid Biopsy; Liver; Liver Abscess, Pyogenic; Liver Cirrhosis; Liver Diseases; Liver Neoplasms; Longevity; Lung Neoplasms; Luteolin; Lymph Nodes; Lymphocyte Activation; Macaca fascicularis; Macrophages; Mad2 Proteins; Magnetic Resonance Imaging; Male; Mammary Glands, Human; Manganese; Manganese Compounds; MAP Kinase Signaling System; Materials Testing; Maternal Health Services; MCF-7 Cells; Medicaid; Medicine, Chinese Traditional; Melanoma; Membrane Proteins; Mental Health; Mercury; Metal Nanoparticles; Metals, Heavy; Metformin; Methionine Adenosyltransferase; Mice; Mice, Inbred BALB C; Mice, Inbred C3H; Mice, Inbred C57BL; Mice, Inbred CBA; Mice, Knockout; Mice, Nude; Microalgae; Microbial Sensitivity Tests; Microglia; MicroRNAs; Microscopy, Atomic Force; Microscopy, Electron, Scanning; Middle Aged; Mitochondria; Mitochondrial Proteins; Mitral Valve; Mitral Valve Insufficiency; Models, Anatomic; Molecular Structure; Molybdenum; Monocarboxylic Acid Transporters; Moths; MPTP Poisoning; Multigene Family; Multiparametric Magnetic Resonance Imaging; Multiple Myeloma; Muscle, Skeletal; Mutagens; Mutation; Myeloid Cells; Nanocomposites; Nanofibers; Nanomedicine; Nanoparticles; Nanowires; Neoadjuvant Therapy; Neomycin; Neoplasm Grading; Neoplasm Recurrence, Local; Neoplasms; Neoplastic Stem Cells; Neostriatum; Neovascularization, Pathologic; Netherlands; Neuromuscular Agents; Neurons; NF-E2-Related Factor 2; NF-kappa B; Nickel; Nitrogen Oxides; Non-alcoholic Fatty Liver Disease; Nucleosides; Nucleotidyltransferases; Nutritional Status; Obesity, Morbid; Ofloxacin; Oils, Volatile; Oligopeptides; Oncogene Protein v-akt; Optical Imaging; Organic Cation Transport Proteins; Organophosphonates; Osteoarthritis; Osteoarthritis, Hip; Osteoarthritis, Knee; Osteoblasts; Osteogenesis; Oxidation-Reduction; Oxidative Stress; Oxides; Oxygen Isotopes; Pancreas; Pancreaticoduodenectomy; Pandemics; Particle Size; Particulate Matter; Patient Acceptance of Health Care; Patient Compliance; PC-3 Cells; Peptide Fragments; Peptides; Periodontal Attachment Loss; Periodontal Index; Periodontal Pocket; Periodontitis; Peroxides; Peru; Pest Control, Biological; Phosphatidylinositol 3-Kinase; Phosphatidylinositol 3-Kinases; Phylogeny; Pilot Projects; Piperidines; Plant Bark; Plant Extracts; Plant Leaves; Plasmids; Platelet Function Tests; Pneumonia, Viral; Podocytes; Poly (ADP-Ribose) Polymerase-1; Poly(ADP-ribose) Polymerase Inhibitors; Polyethylene Terephthalates; Polymers; Polymorphism, Single Nucleotide; Porosity; Portugal; Positron-Emission Tomography; Postoperative Complications; Postural Balance; Potassium Channels, Inwardly Rectifying; Povidone; Powders; Precancerous Conditions; Precision Medicine; Predictive Value of Tests; Pregnancy; Prenatal Care; Prognosis; Promoter Regions, Genetic; Prospective Studies; Prostatectomy; Prostatic Neoplasms; Proteasome Inhibitors; Protective Agents; Protein Binding; Protein Kinase Inhibitors; Protein Serine-Threonine Kinases; Protein Transport; Proto-Oncogene Proteins B-raf; Proto-Oncogene Proteins c-akt; Psychiatric Nursing; PTEN Phosphohydrolase; Pulmonary Embolism; Pyrimethamine; Radiopharmaceuticals; Rats; Rats, Sprague-Dawley; Rats, Wistar; Reactive Oxygen Species; Receptor, ErbB-2; Receptor, IGF Type 1; Receptors, Estrogen; Receptors, G-Protein-Coupled; Recombinational DNA Repair; Recovery of Function; Regional Blood Flow; Renal Dialysis; Renin; Renin-Angiotensin System; Reperfusion Injury; Reproducibility of Results; Republic of Korea; Respiratory Distress Syndrome; Retrospective Studies; Rhodamines; Risk Assessment; Risk Factors; RNA, Long Noncoding; RNA, Messenger; Running; Saccharomyces cerevisiae; Saccharomyces cerevisiae Proteins; Salinity; Salmeterol Xinafoate; Sarcoma; Seasons; Shoulder Injuries; Signal Transduction; Silicon Dioxide; Silver; Sirtuin 1; Sirtuins; Skull Fractures; Social Determinants of Health; Sodium; Sodium Fluoride; Sodium Potassium Chloride Symporter Inhibitors; Sodium-Glucose Transporter 2 Inhibitors; Soil; Soil Pollutants; Spain; Spectrophotometry; Spectroscopy, Fourier Transform Infrared; Staphylococcal Protein A; Staphylococcus aureus; Stem Cells; Stereoisomerism; Stomach Neoplasms; Streptomyces; Strontium; Structure-Activity Relationship; Students, Nursing; Substance-Related Disorders; Succinic Acid; Sulfur; Surface Properties; Survival Rate; Survivin; Symporters; T-Lymphocytes; Temozolomide; Tensile Strength; Thiazoles; Thiobacillus; Thiohydantoins; Thiourea; Thrombectomy; Time Factors; Titanium; Tobacco Mosaic Virus; Tobacco Use Disorder; Toll-Like Receptor 4; Toluene; Tomography, X-Ray Computed; TOR Serine-Threonine Kinases; Toxicity Tests, Acute; Toxicity Tests, Subacute; Transcriptional Activation; Treatment Outcome; Troponin I; Tumor Cells, Cultured; Tumor Escape; Tumor Hypoxia; Tumor Microenvironment; Tumor Necrosis Factor Inhibitors; Tumor Necrosis Factor-alpha; Tyrosine; Ubiquitin-Protein Ligases; Ubiquitination; Ultrasonic Waves; United Kingdom; United States; United States Department of Veterans Affairs; Up-Regulation; Urea; Uric Acid; Urinary Bladder Neoplasms; Urinary Bladder, Neurogenic; Urine; Urodynamics; User-Computer Interface; Vemurafenib; Verbenaceae; Veterans; Veterans Health; Viral Load; Virtual Reality; Vitiligo; Water Pollutants, Chemical; Wildfires; Wnt Signaling Pathway; Wound Healing; X-Ray Diffraction; Xenograft Model Antitumor Assays; Xylenes; Young Adult; Zinc; Zinc Oxide; Zinc Sulfate; Zoonoses

2021
Glutamate as chemotactic fuel for diffuse glioma cells: are they glutamate suckers?
    Biochimica et biophysica acta, 2014, Volume: 1846, Issue:1

    Topics: Animals; Brain Neoplasms; Cell Transformation, Neoplastic; Chemotaxis; Enzyme Inhibitors; Glioma; Glutamic Acid; Glutamine; Humans; Isocitrate Dehydrogenase

2014
Metabolic therapy: a new paradigm for managing malignant brain cancer.
    Cancer letters, 2015, Jan-28, Volume: 356, Issue:2 Pt A

    Topics: Brain Neoplasms; Cytomegalovirus; Diet; Diet, Ketogenic; Energy Metabolism; Glioblastoma; Glucose; Glutamine; Glycolysis; Humans; Macrophages; Microglia; Mitochondria; Treatment Outcome; Tumor Microenvironment

2015
Vanishing pineal mass in a young patient without therapy: Case report and review of the literature.
    The neuroradiology journal, 2016, Volume: 29, Issue:5

    Topics: Adolescent; Aspartic Acid; Brain Neoplasms; Choline; Electroencephalography; Female; Glutamic Acid; Glutamine; Headache; Humans; Hydrocephalus; Magnetic Resonance Imaging; Pineal Gland; Pinealoma; Recovery of Function; Tomography, X-Ray Computed

2016
Glutamine Addiction In Gliomas.
    Neurochemical research, 2017, Volume: 42, Issue:6

    Topics: Animals; Antineoplastic Agents; Brain Neoplasms; Cell Proliferation; Energy Metabolism; Glioma; Glutamine; Glycolysis; Humans

2017
Metabolism and brain cancer.
    Clinics (Sao Paulo, Brazil), 2011, Volume: 66 Suppl 1

    Topics: Brain Neoplasms; Cell Proliferation; Cell Transformation, Neoplastic; Citric Acid Cycle; Glutaminase; Glutamine; Glycolysis; Humans; Oncogenes; Pentose Phosphate Pathway; Stem Cells

2011
Exploiting metabolic differences in glioma therapy.
    Current drug discovery technologies, 2012, Volume: 9, Issue:4

    Topics: Brain Neoplasms; Glioma; Glutamic Acid; Glutamine; Humans; Hypoxia-Inducible Factor 1; NAD; NADP; Signal Transduction

2012
Proton magnetic resonance spectroscopic evaluation of brain tumor metabolism.
    Seminars in oncology, 2004, Volume: 31, Issue:5

    Topics: Alanine; Aspartic Acid; Brain Neoplasms; Choline; Creatine; Glioma; Glutamic Acid; Glutamine; Humans; Inositol; Lactic Acid; Lipid Metabolism; Magnetic Resonance Spectroscopy; Phosphocreatine

2004

Trials

6 trial(s) available for glutamine and Benign Neoplasms, Brain

ArticleYear
Psychological distress among health care professionals of the three COVID-19 most affected Regions in Cameroon: Prevalence and associated factors.
    Annales medico-psychologiques, 2021, Volume: 179, Issue:2

    Topics: 3' Untranslated Regions; 5'-Nucleotidase; A549 Cells; Accidental Falls; Acetylcholinesterase; Acrylic Resins; Actinobacillus; Acute Disease; Acute Kidney Injury; Adaptor Proteins, Signal Transducing; Adenosine; Adenosine Triphosphate; Administration, Inhalation; Administration, Oral; Adolescent; Adult; Advance Care Planning; Africa, Northern; Age Factors; Aged; Aged, 80 and over; Air Pollutants; Air Pollution; Air Pollution, Indoor; Albendazole; Aluminum Oxide; Anastomosis, Surgical; Ancylostoma; Ancylostomiasis; Androstadienes; Angiogenesis Inhibitors; Angiotensin II; Animals; Anti-Bacterial Agents; Anti-Infective Agents; Antibodies, Bispecific; Antibodies, Viral; Anticoagulants; Antihypertensive Agents; Antinematodal Agents; Antineoplastic Agents; Antineoplastic Agents, Immunological; Antineoplastic Combined Chemotherapy Protocols; Antioxidants; Antiporters; Antiviral Agents; Apoptosis; Aptamers, Nucleotide; Aromatase Inhibitors; Asian People; Astrocytes; Atrial Fibrillation; Auditory Threshold; Aurora Kinase B; Australia; Autophagy; Autophagy-Related Protein 5; Autotrophic Processes; Bacillus cereus; Bacillus thuringiensis; Bacterial Proteins; Beclin-1; Belgium; Benzene; Benzene Derivatives; Benzhydryl Compounds; beta Catenin; beta-Arrestin 2; Biliary Tract Diseases; Biofilms; Biofuels; Biomarkers; Biomarkers, Tumor; Biomass; Biomechanical Phenomena; Bioreactors; Biosensing Techniques; Biosynthetic Pathways; Bismuth; Blood Platelets; Bone and Bones; Bone Regeneration; Bortezomib; Botulinum Toxins, Type A; Brain; Brain Injuries; Brain Ischemia; Brain Neoplasms; Breast Neoplasms; Breath Tests; Bronchodilator Agents; Calcium Phosphates; Cannabis; Carbon Dioxide; Carbon Isotopes; Carcinogenesis; Carcinoma, Hepatocellular; Carcinoma, Non-Small-Cell Lung; Carcinoma, Squamous Cell; Cardiac Resynchronization Therapy; Cardiac Resynchronization Therapy Devices; Cardiomyopathies; Cardiovascular Diseases; Cariostatic Agents; Case Managers; Case-Control Studies; Catalysis; Cation Transport Proteins; CD8-Positive T-Lymphocytes; Cecropia Plant; Cell Adhesion; Cell Count; Cell Differentiation; Cell Division; Cell Line; Cell Line, Tumor; Cell Membrane; Cell Movement; Cell Proliferation; Cell Self Renewal; Cell Survival; Cells, Cultured; Cellular Reprogramming; Cellulose; Charcoal; Chemical and Drug Induced Liver Injury; Chemical Phenomena; Chemokines; Chemoradiotherapy; Chemoreceptor Cells; Child; Child Abuse; Child, Preschool; China; Chlorogenic Acid; Chloroquine; Chromatography, Gas; Chronic Disease; Clinical Competence; Coated Materials, Biocompatible; Cochlea; Cohort Studies; Color; Comorbidity; Computer Simulation; Computer-Aided Design; Contraception; Contraceptive Agents, Female; Contrast Media; COP-Coated Vesicles; Coronavirus Infections; Cost of Illness; Coturnix; COVID-19; Creatinine; Cross-Over Studies; Cross-Sectional Studies; Culex; Curriculum; Cyclic N-Oxides; Cytokines; Cytoplasm; Cytotoxicity, Immunologic; Cytotoxins; Databases, Factual; Deep Learning; Delivery, Obstetric; Denitrification; Dental Caries; Denture, Complete; Dexamethasone; Diabetes Complications; Diabetes Mellitus; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 2; Dielectric Spectroscopy; Diet, High-Fat; Dietary Fiber; Disease Models, Animal; Disease Progression; DNA; DNA Copy Number Variations; DNA, Mitochondrial; Dog Diseases; Dogs; Dopaminergic Neurons; Double-Blind Method; Down-Regulation; Doxorubicin; Drug Carriers; Drug Design; Drug Interactions; Drug Resistance, Bacterial; Drug Resistance, Neoplasm; Drug-Related Side Effects and Adverse Reactions; Drugs, Chinese Herbal; Dry Powder Inhalers; Dust; E2F1 Transcription Factor; Ecosystem; Education, Nursing; Education, Nursing, Baccalaureate; Electric Impedance; Electricity; Electrocardiography; Electrochemical Techniques; Electrochemistry; Electrodes; Electrophoresis, Polyacrylamide Gel; Endoplasmic Reticulum; Endothelial Cells; Environmental Monitoring; Enzyme Inhibitors; Epithelial Cells; Epithelial-Mesenchymal Transition; Esophageal Neoplasms; Esophageal Squamous Cell Carcinoma; Estrogen Receptor Modulators; Europe; Evoked Potentials, Auditory, Brain Stem; Exosomes; Feasibility Studies; Female; Ferricyanides; Ferrocyanides; Fibrinogen; Finite Element Analysis; Fistula; Fluorescent Dyes; Fluorides, Topical; Fluorodeoxyglucose F18; Fluticasone; Follow-Up Studies; Food Contamination; Food Microbiology; Foods, Specialized; Forensic Medicine; Frail Elderly; France; Free Radicals; Fresh Water; Fungi; Fungicides, Industrial; Galactosamine; Gastrointestinal Neoplasms; Gene Expression Profiling; Gene Expression Regulation, Neoplastic; Gene Frequency; Genetic Predisposition to Disease; Genotype; Gingival Hemorrhage; Glioblastoma; Glioma; Glomerular Filtration Rate; Glomerulosclerosis, Focal Segmental; Glucose; Glucose Transport Proteins, Facilitative; Glucosides; Glutamine; Glycolysis; Gold; GPI-Linked Proteins; Gram-Negative Bacteria; Gram-Positive Bacteria; Graphite; Haplotypes; HCT116 Cells; Healthy Volunteers; Hearing Loss; Heart Failure; Hedgehog Proteins; HEK293 Cells; HeLa Cells; Hemodynamics; Hemorrhage; Hepatocytes; Hippo Signaling Pathway; Histone Deacetylases; Homeostasis; Hospital Mortality; Hospitalization; Humans; Hydantoins; Hydrazines; Hydrogen Peroxide; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Hydroxylamines; Hypoglycemic Agents; Immunity, Innate; Immunoglobulin G; Immunohistochemistry; Immunologic Factors; Immunomodulation; Immunophenotyping; Immunotherapy; Incidence; Indazoles; Indonesia; Infant; Infant, Newborn; Infarction, Middle Cerebral Artery; Inflammation; Injections, Intramuscular; Insecticides; Insulin-Like Growth Factor I; Insurance, Health; Intention to Treat Analysis; Interleukin-1 Receptor-Associated Kinases; Interleukin-6; Intrauterine Devices; Intrauterine Devices, Copper; Iron; Ischemia; Jordan; Keratinocytes; Kidney; Kidney Diseases; Kir5.1 Channel; Klebsiella Infections; Klebsiella pneumoniae; Lab-On-A-Chip Devices; Laparoscopy; Lasers; Lasers, Semiconductor; Lenalidomide; Leptin; Lethal Dose 50; Levonorgestrel; Limit of Detection; Lipid Metabolism; Lipid Metabolism Disorders; Lipogenesis; Lipopolysaccharides; Liquid Biopsy; Liver; Liver Abscess, Pyogenic; Liver Cirrhosis; Liver Diseases; Liver Neoplasms; Longevity; Lung Neoplasms; Luteolin; Lymph Nodes; Lymphocyte Activation; Macaca fascicularis; Macrophages; Mad2 Proteins; Magnetic Resonance Imaging; Male; Mammary Glands, Human; Manganese; Manganese Compounds; MAP Kinase Signaling System; Materials Testing; Maternal Health Services; MCF-7 Cells; Medicaid; Medicine, Chinese Traditional; Melanoma; Membrane Proteins; Mental Health; Mercury; Metal Nanoparticles; Metals, Heavy; Metformin; Methionine Adenosyltransferase; Mice; Mice, Inbred BALB C; Mice, Inbred C3H; Mice, Inbred C57BL; Mice, Inbred CBA; Mice, Knockout; Mice, Nude; Microalgae; Microbial Sensitivity Tests; Microglia; MicroRNAs; Microscopy, Atomic Force; Microscopy, Electron, Scanning; Middle Aged; Mitochondria; Mitochondrial Proteins; Mitral Valve; Mitral Valve Insufficiency; Models, Anatomic; Molecular Structure; Molybdenum; Monocarboxylic Acid Transporters; Moths; MPTP Poisoning; Multigene Family; Multiparametric Magnetic Resonance Imaging; Multiple Myeloma; Muscle, Skeletal; Mutagens; Mutation; Myeloid Cells; Nanocomposites; Nanofibers; Nanomedicine; Nanoparticles; Nanowires; Neoadjuvant Therapy; Neomycin; Neoplasm Grading; Neoplasm Recurrence, Local; Neoplasms; Neoplastic Stem Cells; Neostriatum; Neovascularization, Pathologic; Netherlands; Neuromuscular Agents; Neurons; NF-E2-Related Factor 2; NF-kappa B; Nickel; Nitrogen Oxides; Non-alcoholic Fatty Liver Disease; Nucleosides; Nucleotidyltransferases; Nutritional Status; Obesity, Morbid; Ofloxacin; Oils, Volatile; Oligopeptides; Oncogene Protein v-akt; Optical Imaging; Organic Cation Transport Proteins; Organophosphonates; Osteoarthritis; Osteoarthritis, Hip; Osteoarthritis, Knee; Osteoblasts; Osteogenesis; Oxidation-Reduction; Oxidative Stress; Oxides; Oxygen Isotopes; Pancreas; Pancreaticoduodenectomy; Pandemics; Particle Size; Particulate Matter; Patient Acceptance of Health Care; Patient Compliance; PC-3 Cells; Peptide Fragments; Peptides; Periodontal Attachment Loss; Periodontal Index; Periodontal Pocket; Periodontitis; Peroxides; Peru; Pest Control, Biological; Phosphatidylinositol 3-Kinase; Phosphatidylinositol 3-Kinases; Phylogeny; Pilot Projects; Piperidines; Plant Bark; Plant Extracts; Plant Leaves; Plasmids; Platelet Function Tests; Pneumonia, Viral; Podocytes; Poly (ADP-Ribose) Polymerase-1; Poly(ADP-ribose) Polymerase Inhibitors; Polyethylene Terephthalates; Polymers; Polymorphism, Single Nucleotide; Porosity; Portugal; Positron-Emission Tomography; Postoperative Complications; Postural Balance; Potassium Channels, Inwardly Rectifying; Povidone; Powders; Precancerous Conditions; Precision Medicine; Predictive Value of Tests; Pregnancy; Prenatal Care; Prognosis; Promoter Regions, Genetic; Prospective Studies; Prostatectomy; Prostatic Neoplasms; Proteasome Inhibitors; Protective Agents; Protein Binding; Protein Kinase Inhibitors; Protein Serine-Threonine Kinases; Protein Transport; Proto-Oncogene Proteins B-raf; Proto-Oncogene Proteins c-akt; Psychiatric Nursing; PTEN Phosphohydrolase; Pulmonary Embolism; Pyrimethamine; Radiopharmaceuticals; Rats; Rats, Sprague-Dawley; Rats, Wistar; Reactive Oxygen Species; Receptor, ErbB-2; Receptor, IGF Type 1; Receptors, Estrogen; Receptors, G-Protein-Coupled; Recombinational DNA Repair; Recovery of Function; Regional Blood Flow; Renal Dialysis; Renin; Renin-Angiotensin System; Reperfusion Injury; Reproducibility of Results; Republic of Korea; Respiratory Distress Syndrome; Retrospective Studies; Rhodamines; Risk Assessment; Risk Factors; RNA, Long Noncoding; RNA, Messenger; Running; Saccharomyces cerevisiae; Saccharomyces cerevisiae Proteins; Salinity; Salmeterol Xinafoate; Sarcoma; Seasons; Shoulder Injuries; Signal Transduction; Silicon Dioxide; Silver; Sirtuin 1; Sirtuins; Skull Fractures; Social Determinants of Health; Sodium; Sodium Fluoride; Sodium Potassium Chloride Symporter Inhibitors; Sodium-Glucose Transporter 2 Inhibitors; Soil; Soil Pollutants; Spain; Spectrophotometry; Spectroscopy, Fourier Transform Infrared; Staphylococcal Protein A; Staphylococcus aureus; Stem Cells; Stereoisomerism; Stomach Neoplasms; Streptomyces; Strontium; Structure-Activity Relationship; Students, Nursing; Substance-Related Disorders; Succinic Acid; Sulfur; Surface Properties; Survival Rate; Survivin; Symporters; T-Lymphocytes; Temozolomide; Tensile Strength; Thiazoles; Thiobacillus; Thiohydantoins; Thiourea; Thrombectomy; Time Factors; Titanium; Tobacco Mosaic Virus; Tobacco Use Disorder; Toll-Like Receptor 4; Toluene; Tomography, X-Ray Computed; TOR Serine-Threonine Kinases; Toxicity Tests, Acute; Toxicity Tests, Subacute; Transcriptional Activation; Treatment Outcome; Troponin I; Tumor Cells, Cultured; Tumor Escape; Tumor Hypoxia; Tumor Microenvironment; Tumor Necrosis Factor Inhibitors; Tumor Necrosis Factor-alpha; Tyrosine; Ubiquitin-Protein Ligases; Ubiquitination; Ultrasonic Waves; United Kingdom; United States; United States Department of Veterans Affairs; Up-Regulation; Urea; Uric Acid; Urinary Bladder Neoplasms; Urinary Bladder, Neurogenic; Urine; Urodynamics; User-Computer Interface; Vemurafenib; Verbenaceae; Veterans; Veterans Health; Viral Load; Virtual Reality; Vitiligo; Water Pollutants, Chemical; Wildfires; Wnt Signaling Pathway; Wound Healing; X-Ray Diffraction; Xenograft Model Antitumor Assays; Xylenes; Young Adult; Zinc; Zinc Oxide; Zinc Sulfate; Zoonoses

2021
Characterization of oligodendrogliomas using short echo time 1H MR spectroscopic imaging.
    NMR in biomedicine, 2003, Volume: 16, Issue:1

    Topics: Adult; Aspartic Acid; Biomarkers, Tumor; Brain Neoplasms; Choline; Dipeptides; Female; Glutamic Acid; Glutamine; Humans; Inositol; Magnetic Resonance Spectroscopy; Male; Middle Aged; Oligodendroglioma; Reproducibility of Results; Sensitivity and Specificity

2003
Phase II study of antineoplaston A10 and AS2-1 in children with recurrent and progressive multicentric glioma : a preliminary report.
    Drugs in R&D, 2004, Volume: 5, Issue:6

    Topics: Adolescent; Antineoplastic Agents; Astrocytoma; Benzeneacetamides; Brain Neoplasms; Child; Child, Preschool; Disease Progression; Drug Combinations; Drug Therapy, Combination; Female; Glioma; Glutamine; Humans; Infant; Magnetic Resonance Imaging; Male; Neoplasm Recurrence, Local; Phenylacetates; Piperidones; Survival Analysis; Treatment Outcome

2004
Long-term survival of high-risk pediatric patients with primitive neuroectodermal tumors treated with antineoplastons A10 and AS2-1.
    Integrative cancer therapies, 2005, Volume: 4, Issue:2

    Topics: Antineoplastic Agents; Benzeneacetamides; Brain Neoplasms; Child, Preschool; Disease Progression; Drug Combinations; Drug Therapy, Combination; Female; Glutamine; Humans; Infant; Male; Neoplasm Recurrence, Local; Neuroectodermal Tumors, Primitive; Phenylacetates; Piperidones; Survival Analysis; Treatment Outcome

2005
A phase I and pharmacokinetic study of intravenous phenylacetate in patients with cancer.
    Cancer research, 1994, Apr-01, Volume: 54, Issue:7

    Topics: Adult; Aged; Antineoplastic Agents; Brain Neoplasms; Drug Administration Schedule; Female; Glioblastoma; Glutamine; Humans; Infusions, Intravenous; Injections, Intravenous; Male; Middle Aged; Neoplasms; Phenylacetates

1994
Phase II study of antineoplastons A10 (NSC 648539) and AS2-1 (NSC 620261) in patients with recurrent glioma.
    Mayo Clinic proceedings, 1999, Volume: 74, Issue:2

    Topics: Adult; Antineoplastic Agents; Astrocytoma; Benzeneacetamides; Brain Neoplasms; Confusion; Disorders of Excessive Somnolence; Drug Administration Schedule; Drug Combinations; Female; Glioblastoma; Glutamine; Humans; Injections, Intravenous; Male; Middle Aged; Patient Selection; Phenylacetates; Piperidones; Seizures; Severity of Illness Index; Treatment Outcome

1999

Other Studies

67 other study(ies) available for glutamine and Benign Neoplasms, Brain

ArticleYear
Circ-CREBBP promotes cell tumorigenesis and glutamine catabolism in glioma by regulating miR-375/glutaminase axis.
    Brain research, 2022, 01-15, Volume: 1775

    Topics: Brain Neoplasms; Carcinogenesis; Cell Proliferation; CREB-Binding Protein; Female; Gene Expression Regulation, Neoplastic; Glioma; Glutaminase; Glutamine; Humans; Male; MicroRNAs; Middle Aged; RNA, Circular; Survival Rate

2022
Sex differences in brain tumor glutamine metabolism reveal sex-specific vulnerabilities to treatment.
    Med (New York, N.Y.), 2022, 11-11, Volume: 3, Issue:11

    Topics: Animals; Brain Neoplasms; Citric Acid Cycle; Female; Glioma; Glutamic Acid; Glutamine; Humans; Male; Mice; Pyruvate Carboxylase; Sex Characteristics

2022
Evaluation of (2S,4S)-4-[
    Molecular pharmaceutics, 2023, 10-02, Volume: 20, Issue:10

    Topics: Animals; Brain Neoplasms; Cell Line, Tumor; Glioma; Glutamine; Lung Neoplasms; Male; Mice; Mice, Nude; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Radiopharmaceuticals; Tissue Distribution

2023
Novel IDH1-Targeted Glioma Therapies.
    CNS drugs, 2019, Volume: 33, Issue:12

    Topics: Antineoplastic Agents; Blood-Brain Barrier; Brain Neoplasms; Cell Line, Tumor; Enzyme Inhibitors; Glioma; Glutamine; Glutarates; Humans; Isocitrate Dehydrogenase; Mutation; Poly(ADP-ribose) Polymerases; Prognosis

2019
Using arterial-venous analysis to characterize cancer metabolic consumption in patients.
    Nature communications, 2020, 06-23, Volume: 11, Issue:1

    Topics: Acetylcarnitine; Adult; Aged; Agmatine; Biomarkers, Tumor; Blood; Blood Chemical Analysis; Blood Glucose; Blood Vessels; Brain Neoplasms; Female; Glioma; Glucose; Glutamine; Glutarates; Humans; Isocitrate Dehydrogenase; Male; Metabolomics; Middle Aged; Ornithine; Putrescine; Uridine Monophosphate; Young Adult

2020
Characterization of dysregulated glutamine metabolism in human glioma tissue with
    Scientific reports, 2020, 11-24, Volume: 10, Issue:1

    Topics: Adult; Aged; Biomarkers, Tumor; Brain Neoplasms; Disease Progression; Female; Glioma; Glutamine; Humans; Interleukin-1beta; Interleukin-8; Middle Aged; Neoplasm Grading; Pilot Projects; Principal Component Analysis; Proton Magnetic Resonance Spectroscopy

2020
Glioma cells require one-carbon metabolism to survive glutamine starvation.
    Acta neuropathologica communications, 2021, 01-19, Volume: 9, Issue:1

    Topics: Aminohydrolases; Autophagy; Brain Neoplasms; Cell Line, Tumor; Cell Proliferation; Cell Survival; Gene Expression Profiling; Gene Expression Regulation, Neoplastic; Glioblastoma; Glutamine; Glycine; Humans; Magnetic Resonance Spectroscopy; Metabolomics; Methylenetetrahydrofolate Dehydrogenase (NADP); Multifunctional Enzymes; Serine; Tumor Microenvironment; Up-Regulation

2021
MiR-200c-based metabolic modulation in glioblastoma cells as a strategy to overcome tumor chemoresistance.
    Human molecular genetics, 2021, 11-16, Volume: 30, Issue:23

    Topics: Antineoplastic Agents; Brain Neoplasms; Cell Line, Tumor; Drug Resistance, Neoplasm; Energy Metabolism; Gene Expression Regulation, Neoplastic; Glioblastoma; Glucose; Glutamine; Humans; MicroRNAs; RNA Interference; RNA, Messenger

2021
mTORC2 Regulates Amino Acid Metabolism in Cancer by Phosphorylation of the Cystine-Glutamate Antiporter xCT.
    Molecular cell, 2017, Jul-06, Volume: 67, Issue:1

    Topics: A549 Cells; Amino Acid Transport System y+; Brain Neoplasms; Cysteine; Glioblastoma; Glutamine; Glutathione; HEK293 Cells; Humans; Mechanistic Target of Rapamycin Complex 1; Multiprotein Complexes; Mutation; Phosphorylation; Protein Binding; Proteomics; RNA Interference; Serine; Tandem Mass Spectrometry; Time Factors; TOR Serine-Threonine Kinases; Transfection; Tumor Microenvironment

2017
Efficient Mitochondrial Glutamine Targeting Prevails Over Glioblastoma Metabolic Plasticity.
    Clinical cancer research : an official journal of the American Association for Cancer Research, 2017, Oct-15, Volume: 23, Issue:20

    Topics: Animals; Biomarkers; Brain Neoplasms; Cell Line, Tumor; Cell Proliferation; Cluster Analysis; Computational Biology; Disease Models, Animal; Energy Metabolism; Gene Expression Profiling; Glioblastoma; Glucose; Glutamine; Heterografts; Humans; Metabolomics; Mice; Mitochondria; Models, Biological; Phenotype

2017
Measurement of
    FEBS letters, 2017, Volume: 591, Issue:21

    Topics: Acetates; Brain Neoplasms; Carbon Isotopes; Female; Glutamic Acid; Glutamine; Humans; Male

2017
Imaging Brain Metastasis Patients With 18F-(2S,4R)-4-Fluoroglutamine.
    Clinical nuclear medicine, 2018, Volume: 43, Issue:11

    Topics: Adult; Aged; Brain Neoplasms; Female; Fluorodeoxyglucose F18; Glutamine; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Positron Emission Tomography Computed Tomography; Whole Body Imaging

2018
Provocative Question: Should Ketogenic Metabolic Therapy Become the Standard of Care for Glioblastoma?
    Neurochemical research, 2019, Volume: 44, Issue:10

    Topics: Brain Neoplasms; Glioblastoma; Glucose; Glutamine; Humans; Ketone Bodies; Mitochondria; Standard of Care; Temozolomide; Tumor Microenvironment

2019
Therapeutic benefit of combining calorie-restricted ketogenic diet and glutamine targeting in late-stage experimental glioblastoma.
    Communications biology, 2019, Volume: 2

    Topics: Animals; Body Weight; Brain; Brain Neoplasms; Caloric Restriction; Cell Line, Tumor; Cell Proliferation; Diazooxonorleucine; Diet, Ketogenic; Disease Models, Animal; Female; Fermentation; Glioblastoma; Glucose; Glutamine; Humans; Immunohistochemistry; Ketone Bodies; Ketones; Male; Mice; Mice, Inbred C57BL; Neoplasm Transplantation

2019
PI3K/mTOR inhibition of IDH1 mutant glioma leads to reduced 2HG production that is associated with increased survival.
    Scientific reports, 2019, 07-19, Volume: 9, Issue:1

    Topics: Adaptor Proteins, Signal Transducing; Animals; Astrocytes; Brain Neoplasms; Cell Cycle Proteins; Cell Line, Transformed; Glioma; Glucose; Glutamine; Glutarates; Humans; Isocitrate Dehydrogenase; Kaplan-Meier Estimate; Mice; Neoplasm Proteins; Nuclear Magnetic Resonance, Biomolecular; Phosphatidylinositol 3-Kinases; Phosphorylation; Protein Processing, Post-Translational; Quinoxalines; Ribosomal Protein S6 Kinases; Signal Transduction; Sulfonamides; TOR Serine-Threonine Kinases; Xenograft Model Antitumor Assays

2019
Similar pyruvate kinase modifications in glioblastoma cells by 7β-hydroxycholesterol and glutamine withdrawal.
    Biochemical pharmacology, 2013, Jul-01, Volume: 86, Issue:1

    Topics: AMP-Activated Protein Kinases; Animals; Brain Neoplasms; Cell Cycle; Cell Line, Tumor; Cell Proliferation; Cyclin D1; Cyclin E; Enzyme Activation; Glioblastoma; Glutamine; Glycolysis; Hydroxycholesterols; Phosphoenolpyruvate; Pyruvate Kinase; Rats; Stress, Physiological

2013
A comparative study of short- and long-TE ¹H MRS at 3 T for in vivo detection of 2-hydroxyglutarate in brain tumors.
    NMR in biomedicine, 2013, Volume: 26, Issue:10

    Topics: Adult; Aspartic Acid; Brain Neoplasms; gamma-Aminobutyric Acid; Glioma; Glutamic Acid; Glutamine; Glutarates; Humans; Isocitrate Dehydrogenase; Magnetic Resonance Spectroscopy; Middle Aged; Mutation; Phantoms, Imaging; Protons; Young Adult

2013
Asparagine depletion potentiates the cytotoxic effect of chemotherapy against brain tumors.
    Molecular cancer research : MCR, 2014, Volume: 12, Issue:5

    Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Asparagine; Aspartate-Ammonia Ligase; Brain Neoplasms; Cell Growth Processes; Cell Line, Tumor; Dacarbazine; DNA Damage; Drug Synergism; Glioblastoma; Glutamine; Humans; Male; Medulloblastoma; Mice; Mice, Nude; Temozolomide; Xenograft Model Antitumor Assays

2014
Quantitative metabolome analysis profiles activation of glutaminolysis in glioma with IDH1 mutation.
    Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine, 2014, Volume: 35, Issue:6

    Topics: Brain Neoplasms; Cell Line, Tumor; Dacarbazine; Glioma; Glutaminase; Glutamine; Glutarates; HEK293 Cells; Humans; Isocitrate Dehydrogenase; Ketoglutaric Acids; Metabolome; Mutation; Temozolomide

2014
Bevacizumab treatment induces metabolic adaptation toward anaerobic metabolism in glioblastomas.
    Acta neuropathologica, 2015, Volume: 129, Issue:1

    Topics: Adult; Aged; Angiogenesis Inhibitors; Animals; Antibodies, Monoclonal, Humanized; Bevacizumab; Brain; Brain Neoplasms; Female; Glioblastoma; Glutamine; Glutathione; Glycolysis; Humans; L-Lactate Dehydrogenase; Lactic Acid; Male; Mice, SCID; Mice, Transgenic; Middle Aged; Neoplasm Transplantation; Oxidative Stress; Radionuclide Imaging; Rats, Nude

2015
¹H MRS characterization of neurochemical profiles in orthotopic mouse models of human brain tumors.
    NMR in biomedicine, 2015, Volume: 28, Issue:1

    Topics: Animals; Brain Neoplasms; Disease Models, Animal; GABAergic Neurons; Glioblastoma; Glutamine; Humans; Metabolome; Mice; Proton Magnetic Resonance Spectroscopy

2015
Mitochondrial p32 is upregulated in Myc expressing brain cancers and mediates glutamine addiction.
    Oncotarget, 2015, Jan-20, Volume: 6, Issue:2

    Topics: Animals; Brain Neoplasms; Carrier Proteins; Cell Line; Cell Line, Tumor; Cell Proliferation; Gene Expression Regulation, Neoplastic; Glioma; Glutamine; Humans; Immunoblotting; Immunohistochemistry; Interleukin Receptor Common gamma Subunit; Mice, Inbred NOD; Mice, Knockout; Mice, SCID; Mitochondrial Proteins; Models, Genetic; Proto-Oncogene Proteins c-myc; Reverse Transcriptase Polymerase Chain Reaction; RNA Interference; Tumor Burden; Xenograft Model Antitumor Assays

2015
Glutamine-based PET imaging facilitates enhanced metabolic evaluation of gliomas in vivo.
    Science translational medicine, 2015, Feb-11, Volume: 7, Issue:274

    Topics: Blood-Brain Barrier; Brain Neoplasms; Disease Progression; Fluorine Radioisotopes; Glioma; Glutamine; Humans; Positron-Emission Tomography

2015
Compensatory glutamine metabolism promotes glioblastoma resistance to mTOR inhibitor treatment.
    The Journal of clinical investigation, 2015, Volume: 125, Issue:4

    Topics: Aged; Animals; Antineoplastic Combined Chemotherapy Protocols; Benzophenanthridines; Brain Neoplasms; Cell Line, Tumor; Citric Acid Cycle; Drug Resistance, Neoplasm; Drug Synergism; Energy Metabolism; Gas Chromatography-Mass Spectrometry; Glioblastoma; Glutamic Acid; Glutaminase; Glutamine; Glycolysis; Humans; Indoles; Ketoglutaric Acids; Magnetic Resonance Spectroscopy; Male; Metabolome; Mice; Mice, Inbred BALB C; Mice, Nude; Molecular Targeted Therapy; Neoplasm Proteins; Protein Kinase Inhibitors; Purines; RNA, Small Interfering; Rotarod Performance Test; Signal Transduction; Temporal Lobe; TOR Serine-Threonine Kinases; Xenograft Model Antitumor Assays

2015
Complete response and long-term survival (>20 years) of a child with tectal glioma: a case report.
    Pediatric neurosurgery, 2015, Volume: 50, Issue:2

    Topics: Adolescent; Benzeneacetamides; Brain Neoplasms; Drug Combinations; Follow-Up Studies; Glioma; Glutamine; Humans; Male; Neoplasm Recurrence, Local; Phenylacetates; Piperidones; Treatment Outcome

2015
Glutamine synthetase activity fuels nucleotide biosynthesis and supports growth of glutamine-restricted glioblastoma.
    Nature cell biology, 2015, Volume: 17, Issue:12

    Topics: Animals; Astrocytes; Blotting, Western; Brain Neoplasms; Cell Line, Tumor; Cell Proliferation; Cells, Cultured; Citric Acid Cycle; Coculture Techniques; Female; Glioblastoma; Glutamate-Ammonia Ligase; Glutamic Acid; Glutamine; Humans; Male; Mice, Inbred NOD; Mice, SCID; Models, Biological; Neoplastic Stem Cells; Nucleotides; Rats, Sprague-Dawley; Reverse Transcriptase Polymerase Chain Reaction; Transplantation, Heterologous

2015
Rethinking glutamine addiction.
    Nature cell biology, 2015, Volume: 17, Issue:12

    Topics: Animals; Brain Neoplasms; Cell Proliferation; Female; Glioblastoma; Glutamate-Ammonia Ligase; Glutamine; Humans; Male; Nucleotides

2015
Supramolecular Probes for Assessing Glutamine Uptake Enable Semi-Quantitative Metabolic Models in Single Cells.
    Journal of the American Chemical Society, 2016, Mar-09, Volume: 138, Issue:9

    Topics: Brain Neoplasms; Carbocyanines; Cell Line, Tumor; Dose-Response Relationship, Drug; ErbB Receptors; Erlotinib Hydrochloride; Fluorescence Resonance Energy Transfer; Glioblastoma; Glutamine; Humans; Molecular Probes

2016
Evaluation of intracranial neoplasia and noninfectious meningoencephalitis in dogs by use of short echo time, single voxel proton magnetic resonance spectroscopy at 3.0 Tesla.
    American journal of veterinary research, 2016, Volume: 77, Issue:5

    Topics: Animals; Aspartic Acid; Brain Neoplasms; Case-Control Studies; Creatine; Dog Diseases; Dogs; Female; Glioma; Glutamine; Male; Meningoencephalitis; Proton Magnetic Resonance Spectroscopy

2016
War on Glioblastoma Multiforme: 2-Pronged Siege on Glutamine.
    World neurosurgery, 2016, Volume: 91

    Topics: Animals; Brain Neoplasms; Cell Line, Tumor; Glioblastoma; Glutamate-Ammonia Ligase; Glutamine; Humans; Mice; Rats

2016
Refined modelling of the short-T2 signal component and ensuing detection of glutamate and glutamine in short-TE, localised, (1) H MR spectra of human glioma measured at 3 T.
    NMR in biomedicine, 2016, Volume: 29, Issue:7

    Topics: Adult; Algorithms; Biomarkers, Tumor; Brain Neoplasms; Computer Simulation; Female; Glioma; Glutamic Acid; Glutamine; Humans; Male; Middle Aged; Models, Biological; Models, Chemical; Proton Magnetic Resonance Spectroscopy; Reproducibility of Results; Sensitivity and Specificity; Signal Processing, Computer-Assisted

2016
Integrative Network-based Analysis of Magnetic Resonance Spectroscopy and Genome Wide Expression in Glioblastoma multiforme.
    Scientific reports, 2016, 06-28, Volume: 6

    Topics: Adult; Aged; Aged, 80 and over; Aspartic Acid; Brain Neoplasms; Computational Biology; Creatine; Female; Gene Expression Profiling; Gene Expression Regulation, Neoplastic; Genome-Wide Association Study; Glioblastoma; Glutamic Acid; Glutamine; Humans; Magnetic Resonance Imaging; Magnetic Resonance Spectroscopy; Male; Middle Aged; Neoplasm Proteins; Neurons; Oligodendroglia; Prognosis; Prospective Studies; Survival Analysis

2016
Discovery of 6-Diazo-5-oxo-l-norleucine (DON) Prodrugs with Enhanced CSF Delivery in Monkeys: A Potential Treatment for Glioblastoma.
    Journal of medicinal chemistry, 2016, Sep-22, Volume: 59, Issue:18

    Topics: Animals; Antimetabolites, Antineoplastic; Brain Neoplasms; Diazooxonorleucine; Female; Glioblastoma; Glutamine; Haplorhini; Humans; Mice; Mice, Nude; Prodrugs

2016
Glutamine Metabolism in Gliomas.
    Advances in neurobiology, 2016, Volume: 13

    Topics: Brain Neoplasms; Cell Proliferation; Glioma; Glutamic Acid; Glutaminase; Glutamine; Humans; Neoplasm Invasiveness

2016
MicroRNA-153 regulates glutamine metabolism in glioblastoma through targeting glutaminase.
    Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine, 2017, Volume: 39, Issue:2

    Topics: Brain Neoplasms; Cell Growth Processes; Cell Line, Tumor; Down-Regulation; Glioblastoma; Glutaminase; Glutamine; Humans; Immunohistochemistry; In Situ Hybridization; MicroRNAs

2017
Phosphoglycerate Kinase 1 Phosphorylates Beclin1 to Induce Autophagy.
    Molecular cell, 2017, Mar-02, Volume: 65, Issue:5

    Topics: Acetylation; Animals; Autophagosomes; Autophagy; Beclin-1; Brain Neoplasms; Cell Line, Tumor; Cell Proliferation; Class III Phosphatidylinositol 3-Kinases; Female; Glioblastoma; Glutamine; HEK293 Cells; Humans; Mice, Nude; N-Terminal Acetyltransferase A; N-Terminal Acetyltransferase E; Phosphoglycerate Kinase; Phosphorylation; Protein Binding; RNA Interference; Signal Transduction; Time Factors; TOR Serine-Threonine Kinases; Transfection; Tumor Burden; Tumor Hypoxia

2017
Proton MR spectroscopy improves discrimination between tumor and pseudotumoral lesion in solid brain masses.
    AJNR. American journal of neuroradiology, 2009, Volume: 30, Issue:3

    Topics: Adolescent; Adult; Aged; Aspartic Acid; Brain Diseases; Brain Neoplasms; Choline; Diagnosis, Differential; Female; Follow-Up Studies; Glutamine; Humans; Magnetic Resonance Spectroscopy; Male; Middle Aged; Protons; Reproducibility of Results; Retrospective Studies; Young Adult

2009
MRI and MRS of human brain tumors.
    Methods in molecular biology (Clifton, N.J.), 2009, Volume: 520

    Topics: Brain Neoplasms; Glutamic Acid; Glutamine; Humans; Magnetic Resonance Imaging; Magnetic Resonance Spectroscopy

2009
Untreated glioblastoma multiforme: increased myo-inositol and glutamine levels in the contralateral cerebral hemisphere at proton MR spectroscopy.
    Radiology, 2009, Volume: 253, Issue:3

    Topics: Aged; Brain Neoplasms; Case-Control Studies; Female; Glioblastoma; Glutamine; Humans; Inositol; Magnetic Resonance Spectroscopy; Male; Middle Aged; Statistics, Nonparametric

2009
Glutamine targeting inhibits systemic metastasis in the VM-M3 murine tumor model.
    International journal of cancer, 2010, Nov-15, Volume: 127, Issue:10

    Topics: Animals; Antimetabolites, Antineoplastic; Blood Glucose; Body Weight; Brain Neoplasms; Caloric Restriction; Cell Growth Processes; Cell Line, Tumor; Cerebrum; Diazooxonorleucine; Drug Delivery Systems; Female; Glucose; Glutamine; Male; Mice; Neoplasm Metastasis

2010
[2,4-(13)C]β-hydroxybutyrate metabolism in astrocytes and C6 glioblastoma cells.
    Neurochemical research, 2011, Volume: 36, Issue:8

    Topics: 3-Hydroxybutyric Acid; Animals; Aspartic Acid; Astrocytes; Brain Neoplasms; Citric Acid Cycle; Diet, Ketogenic; Glioblastoma; Glucose; Glutamic Acid; Glutamine; Humans; Ketone Bodies; Lactic Acid; Mice; Tumor Cells, Cultured

2011
[Guidelines for specialized nutritional and metabolic support in the critically-ill patient. Update. Consensus of the Spanish Society of Intensive Care Medicine and Coronary Units-Spanish Society of Parenteral and Enteral Nutrition (SEMICYUC-SENPE): neuro
    Medicina intensiva, 2011, Volume: 35 Suppl 1

    Topics: Blood Glucose; Brain Injuries; Brain Neoplasms; Consciousness Disorders; Contraindications; Critical Care; Critical Illness; Dietary Proteins; Energy Intake; Enteral Nutrition; Glutamine; Humans; Hyperglycemia; Hypnotics and Sedatives; Metabolism; Nutritional Requirements; Parenteral Nutrition; Societies, Medical; Societies, Scientific; Spain; Stroke

2011
Analysis of tumor metabolism reveals mitochondrial glucose oxidation in genetically diverse human glioblastomas in the mouse brain in vivo.
    Cell metabolism, 2012, Jun-06, Volume: 15, Issue:6

    Topics: Animals; Brain Neoplasms; Glioblastoma; Gluconeogenesis; Glucose; Glutamate-Ammonia Ligase; Glutamic Acid; Glutaminase; Glutamine; Glycolysis; Humans; Mice; Mice, Inbred NOD; Mice, SCID; Mitochondria; Neoplasm Transplantation; Neostriatum; Oxidation-Reduction; Phenotype; Pyruvate Carboxylase; Statistics, Nonparametric; Tumor Cells, Cultured

2012
Insulin receptor, IRS1, IRS2, INSIG1, INSIG2, RRAD, and BAIAP2 gene expressions in glioma U87 cells with ERN1 loss of function: effect of hypoxia and glutamine or glucose deprivation.
    Endocrine regulations, 2013, Volume: 47, Issue:1

    Topics: Brain Neoplasms; Cell Hypoxia; Cell Line, Tumor; Endoribonucleases; Gene Deletion; Gene Expression Regulation, Neoplastic; Glioma; Glucose; Glutamine; Humans; Insulin Receptor Substrate Proteins; Intracellular Signaling Peptides and Proteins; Membrane Proteins; Nerve Tissue Proteins; Protein Serine-Threonine Kinases; ras Proteins; Receptor, Insulin

2013
Adult primitive neuroectodermal tumor: proton MR spectroscopic findings with possible application for differential diagnosis.
    Radiology, 2002, Volume: 225, Issue:2

    Topics: Adolescent; Adult; Aged; Aged, 80 and over; Alanine; Astrocytoma; Brain; Brain Neoplasms; Diagnosis, Differential; Female; Glioblastoma; Glutamic Acid; Glutamine; Humans; Magnetic Resonance Imaging; Magnetic Resonance Spectroscopy; Male; Meningeal Neoplasms; Meningioma; Middle Aged; Neuroectodermal Tumors, Primitive; Prospective Studies; Retrospective Studies

2002
1H MR spectroscopy of mesial temporal lobe epilepsies treated with Gamma knife.
    European radiology, 2003, Volume: 13, Issue:5

    Topics: Adult; Aspartic Acid; Brain; Brain Neoplasms; Choline; Creatine; Epilepsy, Temporal Lobe; Female; Follow-Up Studies; Glutamic Acid; Glutamine; Humans; Lipid Metabolism; Lipids; Magnetic Resonance Imaging; Magnetic Resonance Spectroscopy; Male; Postoperative Complications; Radiation Injuries; Radiation Tolerance; Radiosurgery; Seizures; Time Factors; Treatment Failure

2003
Managing social conflict in complementary and alternative medicine research: the case of antineoplastons.
    Integrative cancer therapies, 2004, Volume: 3, Issue:1

    Topics: Benzeneacetamides; Brain Neoplasms; Clinical Trials, Phase II as Topic; Communication; Complementary Therapies; Conflict of Interest; Documentation; Drug Combinations; Glutamine; Humans; Interprofessional Relations; Phenylacetates; Physician's Role; Piperidones; Power, Psychological; Problem Solving; Social Conditions; Trust

2004
Lymphocytic vasculitis mimicking aggressive multifocal cerebral neoplasm: mr imaging and MR spectroscopic appearance.
    AJNR. American journal of neuroradiology, 2005, Volume: 26, Issue:3

    Topics: Adult; Brain; Brain Neoplasms; Choline; Diagnosis, Differential; Female; Glutamic Acid; Glutamine; Humans; Lymphocytes; Magnetic Resonance Imaging; Magnetic Resonance Spectroscopy; Vasculitis, Central Nervous System

2005
[Proton magnetic resonance spectroscopy (1H-MRS) for the diagnosis of brain tumors and the evaluation of treatment].
    Neuro-Chirurgie, 2005, Volume: 51, Issue:3-4 Pt 2

    Topics: Acetates; Alanine; Amino Acids; Brain Neoplasms; Choline; Creatine; Diagnosis, Differential; Glutamic Acid; Glutamine; Humans; Inositol; Lactates; Magnetic Resonance Spectroscopy; Neoplasm Invasiveness; Oligodendroglioma; Phospholipids; Protons; Time Factors

2005
Simultaneous detection of resolved glutamate, glutamine, and gamma-aminobutyric acid at 4 T.
    Journal of magnetic resonance (San Diego, Calif. : 1997), 2007, Volume: 185, Issue:2

    Topics: Algorithms; Brain; Brain Neoplasms; Complex Mixtures; gamma-Aminobutyric Acid; Glutamic Acid; Glutamine; Humans; Magnetic Resonance Spectroscopy; Neurotransmitter Agents

2007
Beyond aerobic glycolysis: transformed cells can engage in glutamine metabolism that exceeds the requirement for protein and nucleotide synthesis.
    Proceedings of the National Academy of Sciences of the United States of America, 2007, Dec-04, Volume: 104, Issue:49

    Topics: Aerobiosis; Brain Neoplasms; Cell Line, Tumor; Cell Proliferation; Cell Transformation, Neoplastic; Citric Acid Cycle; Glioblastoma; Glucose; Glutamine; Glycolysis; Humans; Nucleotides; Protein Biosynthesis

2007
N-acetylcysteine prevents HIV gp 120-related damage of human cultured astrocytes: correlation with glutamine synthase dysfunction.
    BMC neuroscience, 2007, Dec-06, Volume: 8

    Topics: Acetylcysteine; Analysis of Variance; Astrocytes; Astrocytoma; Brain Neoplasms; Cell Death; Cell Line, Tumor; Drug Interactions; Flow Cytometry; Free Radical Scavengers; Glutamate-Ammonia Ligase; Glutamine; HIV Envelope Protein gp120; Humans; In Situ Nick-End Labeling; Male; Malondialdehyde; Middle Aged

2007
Spectral simplification for resolved glutamate and glutamine measurement using a standard STEAM sequence with optimized timing parameters at 3, 4, 4.7, 7, and 9.4T.
    Magnetic resonance in medicine, 2008, Volume: 59, Issue:2

    Topics: Animals; Brain; Brain Neoplasms; Computer Simulation; Glutamic Acid; Glutamine; Humans; Magnetic Resonance Spectroscopy; Male; Phantoms, Imaging; Rats; Rats, Sprague-Dawley

2008
[Amino acid composition of cerebrospinal fluid in the epilepsy syndrome].
    Zhurnal nevropatologii i psikhiatrii imeni S.S. Korsakova (Moscow, Russia : 1952), 1980, Volume: 80, Issue:6

    Topics: Amino Acids; Arachnoiditis; Brain Neoplasms; Chronic Disease; Encephalitis; Epilepsy; Glutamates; Glutamine; Humans; Syndrome

1980
The effect of Antineoplaston, a new antitumor agent on malignant brain tumors.
    The Kurume medical journal, 1995, Volume: 42, Issue:3

    Topics: Adult; Antineoplastic Agents; Astrocytoma; Benzeneacetamides; Brain Neoplasms; Child; Drug Combinations; Female; Glioblastoma; Glioma; Glutamine; Humans; Male; Medulloblastoma; Middle Aged; Phenylacetates; Piperidones

1995
In vivo proton MR spectroscopy of human gliomas: definition of metabolic coordinates for multi-dimensional classification.
    Magnetic resonance in medicine, 1995, Volume: 34, Issue:2

    Topics: Adult; Aspartic Acid; Astrocytoma; Brain Neoplasms; Choline; Cluster Analysis; Creatine; Discriminant Analysis; Female; Glioblastoma; Glioma; Glutamates; Glutamine; Glycine; Humans; Hydrogen; Inositol; Lipid Metabolism; Magnetic Resonance Spectroscopy; Male; Middle Aged; Oligodendroglioma; Protons

1995
Glutathione, but not glutamine, is detected in 13C-NMR spectra of perchloric acid extracts from C6 glioma cells.
    FEBS letters, 1993, Aug-02, Volume: 327, Issue:3

    Topics: Brain Neoplasms; Carbon Isotopes; Glioma; Glutamine; Glutathione; Hydrogen-Ion Concentration; Magnetic Resonance Spectroscopy; Perchlorates; Tumor Cells, Cultured

1993
[1-(13)C]glucose metabolism in the tumoral and nontumoral cerebral tissue of a glioma-bearing rat.
    Journal of neurochemistry, 1999, Volume: 72, Issue:6

    Topics: Alanine; Amino Acids; Analysis of Variance; Animals; Aspartic Acid; Body Weight; Brain; Brain Neoplasms; Carbon Isotopes; Citric Acid Cycle; Female; Functional Laterality; gamma-Aminobutyric Acid; Glioma; Glucose; Glutamic Acid; Glutamine; Magnetic Resonance Imaging; Magnetic Resonance Spectroscopy; Models, Chemical; Nerve Tissue Proteins; Rats; Rats, Wistar; Tumor Cells, Cultured

1999
High glycolytic activity in rat glioma demonstrated in vivo by correlation peak 1H magnetic resonance imaging.
    Cancer research, 2001, Jul-15, Volume: 61, Issue:14

    Topics: Alanine; Animals; Aspartic Acid; Brain Neoplasms; Choline; Creatine; Ethanolamines; Female; Glioma; Glucose; Glutamic Acid; Glutamine; Glycolysis; Lactic Acid; Magnetic Resonance Imaging; Phosphocreatine; Rats; Rats, Sprague-Dawley; Taurine; Tumor Cells, Cultured

2001
Effect of exogenous lactate on rat glioma metabolism.
    Journal of neuroscience research, 2001, Sep-15, Volume: 65, Issue:6

    Topics: Animals; Blood Glucose; Brain; Brain Neoplasms; Carbon; Carbon Radioisotopes; Citric Acid Cycle; Energy Metabolism; Female; Glioma; Glucose; Glutamine; Glycolysis; Lactic Acid; Magnetic Resonance Spectroscopy; NAD; Neurons; Rats; Rats, Wistar; Tumor Cells, Cultured

2001
Non-toxic drug being tested to treat cancer and anemias.
    Journal of the National Cancer Institute, 1992, Sep-16, Volume: 84, Issue:18

    Topics: Anemia; Brain Neoplasms; Glutamine; Humans; Male; Phenylacetates; Phenylbutyrates; Prostatic Neoplasms

1992
Noninvasive differentiation of tumors with use of localized H-1 MR spectroscopy in vivo: initial experience in patients with cerebral tumors.
    Radiology, 1989, Volume: 172, Issue:2

    Topics: Adult; Aspartic Acid; Brain Chemistry; Brain Diseases; Brain Neoplasms; Choline; Creatinine; Cysts; Diagnosis, Differential; Female; Glioma; Glutamine; Humans; Inositol; Lactates; Lactic Acid; Magnetic Resonance Spectroscopy; Male; Meningeal Neoplasms; Meningioma; Middle Aged; Neurilemmoma; Phosphocreatine

1989
Effect of glutamate analogues on brain tumor cell lines.
    Journal of neurochemistry, 1985, Volume: 45, Issue:4

    Topics: 2-Aminoadipic Acid; Aminobutyrates; Brain Neoplasms; Cell Division; Cell Line; Glioma; Glutamates; Glutamic Acid; Glutamine; Homocysteine; Medulloblastoma; Neuroglia; Sarcoma

1985
Amino acid neurotransmitter levels in gliomas and their relationship to the incidence of epilepsy.
    Neurological research, 1988, Volume: 10, Issue:2

    Topics: Amino Acids; Brain Neoplasms; Epilepsy; gamma-Aminobutyric Acid; Glioma; Glutamine; Humans; Neurotransmitter Agents

1988
Decreased cerebrospinal fluid glutamine levels in patients with benign brain tumors.
    Journal of neurochemistry, 1985, Volume: 45, Issue:3

    Topics: Adolescent; Adult; Astrocytoma; Brain Neoplasms; Cerebellar Neoplasms; Child; Chondrosarcoma; Craniopharyngioma; Female; Fibroma; Glutamine; Humans; Male; Medulloblastoma; Meningeal Neoplasms; Meningioma; Middle Aged; Osteoma; Pinealoma; Pituitary Neoplasms

1985
[Relationship between the effect of phenothiazine and butyrophenone and the glutamine level in the blood of schizophrenics].
    Wiener Zeitschrift fur Nervenheilkunde und deren Grenzgebiete, 1968, Volume: 26, Issue:2

    Topics: Brain Neoplasms; Butyrophenones; Epilepsy; Glutamine; Humans; Phenothiazines; Schizophrenia

1968
[Glutamic acid and glutamine in glial brain tumor tissue].
    Ukrains'kyi biokhimichnyi zhurnal, 1967, Volume: 39, Issue:6

    Topics: Ammonia; Animals; Brain Neoplasms; Glioma; Glutamates; Glutaminase; Glutamine; Mice; Neoplasms, Experimental; Neuroglia; Rabbits

1967